<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">40486</article-id><article-id pub-id-type="doi">10.7554/eLife.40486</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Structures of translationally inactive mammalian ribosomes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-118430"><name><surname>Brown</surname><given-names>Alan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0021-0476</contrib-id><email>alan_brown@hms.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118431"><name><surname>Baird</surname><given-names>Matthew R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118432"><name><surname>Yip</surname><given-names>Matthew CJ</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2505-9987</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118433"><name><surname>Murray</surname><given-names>Jason</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8679-8281</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-56279"><name><surname>Shao</surname><given-names>Sichen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2679-5537</contrib-id><email>sichen_shao@hms.harvard.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Biological Chemistry and Molecular Pharmacology</institution><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Cell Biology</institution><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>MRC Laboratory of Molecular Biology</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sonenberg</surname><given-names>Nahum</given-names></name><role>Reviewing Editor</role><aff><institution>McGill University</institution><country>Canada</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Manley</surname><given-names>James L</given-names></name><role>Senior Editor</role><aff><institution>Columbia University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>24</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e40486</elocation-id><history><date date-type="received" iso-8601-date="2018-07-26"><day>26</day><month>07</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-10-12"><day>12</day><month>10</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Brown et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Brown et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-40486-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.40486.001</object-id><p>The cellular levels and activities of ribosomes directly regulate gene expression during numerous physiological processes. The mechanisms that globally repress translation are incompletely understood. Here, we use electron cryomicroscopy to analyze inactive ribosomes isolated from mammalian reticulocytes, the penultimate stage of red blood cell differentiation. We identify two types of ribosomes that are translationally repressed by protein interactions. The first comprises ribosomes sequestered with elongation factor 2 (eEF2) by SERPINE mRNA binding protein 1 (SERBP1) occupying the ribosomal mRNA entrance channel. The second type are translationally repressed by a novel ribosome-binding protein, interferon-related developmental regulator 2 (IFRD2), which spans the P and E sites and inserts a C-terminal helix into the mRNA exit channel to preclude translation. IFRD2 binds ribosomes with a tRNA occupying a noncanonical binding site, the ‘Z site’, on the ribosome. These structures provide functional insights into how ribosomal interactions may suppress translation to regulate gene expression.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>electron cryomicroscopy</kwd><kwd>ribosome</kwd><kwd>in vitro reconstitution</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006691</institution-id><institution>Harvard Medical School</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Brown</surname><given-names>Alan</given-names></name><name><surname>Baird</surname><given-names>Matthew R</given-names></name><name><surname>Yip</surname><given-names>Matthew CJ</given-names></name><name><surname>Shao</surname><given-names>Sichen</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001694</institution-id><institution>International Retinal Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Brown</surname><given-names>Alan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010310</institution-id><institution>E. Matilda Ziegler Foundation for the Blind</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Brown</surname><given-names>Alan</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Murray</surname><given-names>Jason</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001680</institution-id><institution>Charles H. Hood Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Shao</surname><given-names>Sichen</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001341</institution-id><institution>Richard and Susan Smith Family Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Shao</surname><given-names>Sichen</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Mining electron cryomicroscopy data reveals new ribosomal interactions that preclude translation to potentially regulate gene expression.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Translation is an important point of regulation for gene expression. The overall levels and activities of ribosomes are implicated in cellular differentiation, developmental disorders, and cancers (<xref ref-type="bibr" rid="bib13">Buszczak et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Narla and Ebert, 2010</xref>). Red blood cell differentiation and function is especially sensitive to ribosome concentrations and activity. Humans produce over two million red blood cells every second (<xref ref-type="bibr" rid="bib21">Dzierzak and Philipsen, 2013</xref>), with hemoglobin comprising 98% of total protein content of each cell. To achieve this, translation is optimized for hemoglobin production during red blood cell differentiation (<xref ref-type="bibr" rid="bib34">Mills et al., 2016</xref>; <xref ref-type="bibr" rid="bib49">Smith and McNamara, 1971</xref>). This translational program occurs predominantly in enucleated cells, precluding transcriptional control and relying solely on preexisting ribosomes and translational factors before the ribosomes are degraded upon terminal differentiation (<xref ref-type="bibr" rid="bib44">Rowley, 1965</xref>).</p><p>Underscoring the importance of ribosomal activity in blood cell differentiation, mutations in ribosomal proteins, ribosome-assembly factors, and the ribosome-degradation machinery manifest as blood disorders (<xref ref-type="bibr" rid="bib20">Draptchinskaia et al., 1999</xref>; <xref ref-type="bibr" rid="bib22">Ebert et al., 2008</xref>) and are often found in cancers of blood cells (<xref ref-type="bibr" rid="bib17">De Keersmaecker et al., 2013</xref>; <xref ref-type="bibr" rid="bib33">Ljungström et al., 2016</xref>). A recent study demonstrated that mutations that cause Diamond-Blackfan anemia alter global ribosome levels, which dictates the mRNAs that are translated (<xref ref-type="bibr" rid="bib27">Khajuria et al., 2018</xref>). Similarly, mutations in the ubiquitination machinery required to eliminate ribosomes during terminal red blood cell differentiation results in anemia in mice (<xref ref-type="bibr" rid="bib38">Nguyen et al., 2017</xref>).</p><p>Although controlling absolute ribosome levels is an effective mechanism to regulate gene expression, assembling and degrading ribosomes is slow and requires significant energy consumption (<xref ref-type="bibr" rid="bib29">Kressler et al., 2010</xref>; <xref ref-type="bibr" rid="bib59">Warner, 1999</xref>). For faster responses, two mechanisms are known to acutely and reversibly repress global translation in eukaryotes. The first is phosphorylation of translation initiation factor eIF2α, which dampens protein synthesis by preventing the formation of productive translation initiation complexes (<xref ref-type="bibr" rid="bib60">Wek et al., 2006</xref>). In mammals, four distinct kinases phosphorylate eIF2α in response to different cellular stresses, including nutrient deprivation, endoplasmic reticulum (ER) stress, viral infections, and heme deprivation (<xref ref-type="bibr" rid="bib15">Chen, 2014</xref>). The second mechanism is translational repression by the yeast Stm1 protein or its mammalian homolog, SERPINE mRNA-binding protein 1 (SERBP1). Stm1 directly binds and sequesters 80S ribosomes (<xref ref-type="bibr" rid="bib8">Balagopal and Parker, 2011</xref>; <xref ref-type="bibr" rid="bib52">Van Dyke et al., 2006</xref>). This function of Stm1 is thought to preserve ribosomes during nutrient deprivation (<xref ref-type="bibr" rid="bib53">Van Dyke et al., 2013</xref>) and may influence the degradation of some mRNAs (<xref ref-type="bibr" rid="bib8">Balagopal and Parker, 2011</xref>).</p><p>Despite emerging evidence of the importance of global translation levels on short- and long-term gene regulation, other mechanisms for modulating ribosome activities remain poorly characterized. Here, we use electron cryomicroscopy (cryo-EM) to analyze translationally inactive ribosomes isolated from mammalian reticulocytes, the penultimate stage of red blood cell differentiation (<xref ref-type="bibr" rid="bib21">Dzierzak and Philipsen, 2013</xref>). In addition to observing ribosomes silenced by SERBP1, we identify interferon-related developmental regulator 2 (IFRD2) as a novel factor capable of translationally inactivating ribosomes. IFRD2 directly binds 80S ribosomes, precluding binding of mRNA and P-site tRNA. We additionally observe deacylated tRNA occupying a noncanonical binding site on the mammalian ribosome that is exploited by viral internal ribosome entry site (IRES)-mediated translation. We observe tRNA in this site in the presence and absence of either IFRD2 and P-site tRNA. Together, these findings identify new ribosomal interactions that may modulate global translation activity during erythropoiesis and in other differentiating cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Identification of translationally inactive ribosomes in reticulocyte lysate</title><p>We previously used a cell-free translation system derived from rabbit reticulocyte lysate to isolate various ribosomal complexes for cryo-EM analysis (<xref ref-type="bibr" rid="bib12">Brown et al., 2015b</xref>; <xref ref-type="bibr" rid="bib46">Shao et al., 2016</xref>). Despite biochemical enrichment for specific complexes, the target structures generally derived from 10% to 20% of the particles within each cryo-EM dataset. The remaining particles are various translation intermediates and inactive ribosomes that copurify with the target complex. To characterize these reticulocyte ribosomal populations, we reanalyzed a combined cryo-EM dataset of 971,191 ribosomal particles purified from in vitro translation reactions containing a dominant-negative release factor (DN-eRF1) added to enrich for translational termination complexes (<xref ref-type="bibr" rid="bib12">Brown et al., 2015b</xref>). These datasets were imaged under identical conditions, with the only difference being the identity of the stop codon in the mRNA used to program the in vitro translation reactions. As all stop codons adopt the same structural fold (<xref ref-type="bibr" rid="bib12">Brown et al., 2015b</xref>), these samples can be considered biochemically and structurally analogous.</p><p>Three-dimensional classification of the combined dataset of ribosomal particles identified nine structurally distinct classes of 80S ribosomes (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="table" rid="table1">Table 1</xref>). These included the target termination complex and known intermediates of translation. Notably, we did not observe any empty 80S ribosomes lacking a bound tRNA or protein factor. Four classes represented non-translating ribosomes based on the absence of canonical tRNAs. These structures fall into three types of translationally inactive 80S ribosomes (1) bound to eEF2 and SERBP1, (2) bound to IFRD2, and (3) containing a tRNA in a noncanonical binding site.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.40486.002</object-id><label>Figure 1.</label><caption><title>Identification of translationally inactive ribosomal complexes in a cryo-EM dataset.</title><p>In silico classification of a cryo-EM dataset of ribosomal particles reveals known intermediates of translation and translationally inactive 80S ribosomes. The overall resolution and number of particles that make up the reconstruction are shown for each complex.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40486.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Global and local resolution.</title><p>(<bold>A</bold>) Fourier-shell-correlation (FSC) curves for each reported cryo-EM reconstruction. FSC values at 0.5 and 0.143 are indicated with dashed lines. (<bold>B</bold>) The cryo-EM map for each factor colored by local resolution. (<bold>C</bold>) Validation curves.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig1-figsupp1-v2"/></fig></fig-group></sec><sec id="s2-2"><title>SERBP1 traps eEF2 on different conformations of inactive ribosomes</title><p>The two most abundant classes of non-translating ribosomes are distinct conformations (rotated and unrotated) of 80S ribosomes bound to the elongation factor eEF2 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). eEF2 normally catalyzes the translocation of mRNA and peptidyl-tRNA during translation, although its association with inactive ribosomes is well established (<xref ref-type="bibr" rid="bib32">Liu and Qian, 2016</xref>). Closer inspection reveals that all maps of non-translating ribosomes with eEF2 in our dataset also contain SERBP1 in the mRNA entrance channel (<xref ref-type="fig" rid="fig2">Figure 2A,B</xref>). It is possible that eEF2 requires SERBP1 to form stable interactions with inactive ribosomes. Our map resolution (3.4 Å) allows the reassignment of SERBP1 residues from a 5.4 Å-resolution cryo-EM structure of eEF2-SERBP1 on the human ribosome (<xref ref-type="bibr" rid="bib6">Anger et al., 2013</xref>) to produce a model that is more consistent with the structure of Stm1 on the yeast ribosome (<xref ref-type="bibr" rid="bib10">Ben-Shem et al., 2011</xref>) and cross-linking data (<xref ref-type="bibr" rid="bib31">Liu et al., 2015</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.40486.004</object-id><label>Figure 2.</label><caption><title>SERBP1 sequesters eEF2 on inactive ribosomes.</title><p>Comparison of (<bold>A</bold>) SERBP1 (SERPINE1 mRNA-binding protein 1) and eEF2 (eukaryotic elongation factor 2) bound to the rabbit ribosome with (<bold>B</bold>) Stm1 bound to the yeast ribosome (PDB 4V88). (<bold>C</bold>) Path of SERBP1 and (<bold>D</bold>) Stm1 through the mRNA entrance channel. (<bold>E</bold>) Interaction between SERBP1 and eEF2.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40486.005</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Distinct classes of eEF2 and SERBP1 bound to 80S ribosomes.</title><p>(<bold>A</bold>) Overview of the two classes of 80S ribosomes bound to eEF2 and SERBP1 (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). The small ribosomal subunit (SSU) in the rotated conformation is colored in yellow, with the corresponding eEF2 density colored in blue. The other unrotated class is aligned to this map via the large ribosomal subunit (LSU), with the corresponding SSU and eEF2 densities colored in grey and green, respectively. (<bold>B</bold>) Density of SERBP1 (purple) displaying interactions with 18S rRNA and the uS3 protein in the mRNA entrance channel of the small ribosomal subunit (yellow). (<bold>C</bold>) Comparison of the EM map density for SERBP1 (purple) in the rotated (top) or unrotated (bottom) ribosome. (<bold>D</bold>) Comparison of the interactions between the C-terminus of either rabbit SERBP1 (purple, left panel) or yeast Stm1 (pink, right panel) with the indicated proteins of the small ribosomal subunit. (<bold>E</bold>) Map density of the interaction between eEF2 (blue) and SERBP1 (purple). The diphthamide (diph) modification on His715 of eEF2 is indicated. (<bold>F</bold>) Map density for the GDP nucleotide (green) bound to eEF2 (blue). (<bold>G</bold>) Comparison of different conformations of the eEF2 nucleotide-binding domain on the rotated (top) and unrotated (bottom) ribosome.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig2-figsupp1-v2"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40486.006</object-id><label>Figure 2—figure supplement 2.</label><caption><title>Sequence conservation of Stm1 and SERBP1.</title><p>Sequence alignment of four isoforms of rabbit SERBP1 and yeast Stm1, with highly conserved residues highlighted in blue. The segments of SERBP1 isoform two modeled from this work are shown above the sequence alignment, depicted as secondary structure.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig2-figsupp2-v2"/></fig></fig-group><p>SERBP1 and Stm1 interact with the A and P sites of the ribosomal mRNA channel via conserved residues (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), including a DRHS motif (residues 194–197 in SERBP1) that forms a 3<sub>10</sub>-helix around nucleotide C1701 of 18S rRNA (<xref ref-type="fig" rid="fig2">Figure 2C,D</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). The density of SERBP1 is less clear following residue 201 in the unrotated ribosome (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>), potentially the result of averaging splice variants that differ at this site (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). The C-termini of SERBP1 and Stm1 emerge from the mRNA channel to interact with eS10, eS12 and eS31, although the density is only sufficiently resolved to model a short helix of SERBP1 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Unlike Stm1, we observe no interaction between the N terminus of SERBP1 and the ribosomal large subunit.</p><p>At the A site, SERBP1 residues 198 – 201 interact with domain IV of eEF2 (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). This small interface is unlikely to physically anchor eEF2 to the ribosome, and the presence of GDP in the nucleotide-binding pocket of eEF2 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>) despite differences in the switch-loop conformations (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>) indicates that SERBP1 does not impair GTP hydrolysis by eEF2. The exact mechanism for how SERBP1 is able to trap eEF2 on the ribosome is unclear, although there are similarities with the eEF2-inhibitor sordarin (<xref ref-type="bibr" rid="bib39">Pellegrino et al., 2018</xref>). Like SERBP1, sordarin traps eEF2 on the yeast ribosome without impairing GTP hydrolysis or inducing large-scale structural changes in eEF2 (<xref ref-type="bibr" rid="bib39">Pellegrino et al., 2018</xref>). Instead, sordarin binds in a pocket between domains III, IV, and V, and increases interdomain contacts to subtly constrain the domains in conformations that prevent release. SERBP1 may also constrain domain rearrangements necessary for release through its interaction with eEF2 domain IV. Thus, SERBP1 simultaneously removes a ribosome and an abundant translational GTPase from active translation.</p></sec><sec id="s2-3"><title>IFRD2 binds the ribosomal core and is incompatible with translation</title><p>The second most abundant subset of translationally inactive 80S ribosomes contain IFRD2 in the intersubunit space of a nonrotated ribosome, where it occludes tRNA binding to the P and E sites (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and mRNA binding to the mRNA channel. We identified IFRD2 by comparing the predominantly α-helical density with the secondary structure profiles of approximately 150 candidates identified by mass spectrometry of the cryo-EM sample (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). IFRD2 matches the number and length of the helices present in the map and has a sequence that fits regions of the map with well-defined density (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A,B</xref>). Supporting this assignment, both IFRD2 and its paralog IFRD1 co-immunoprecipitate with endogenously tagged ribosomes from mouse embryonic stem cells (<xref ref-type="bibr" rid="bib48">Simsek et al., 2017</xref>), although IFRD1 could be excluded here based on side-chain density (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). IFRD proteins are generally described as transcriptional regulators implicated in cellular differentiation and various human diseases (<xref ref-type="bibr" rid="bib55">Vietor et al., 2002</xref>), although their naming as ‘interferon-related’ is apparently due to a mistaken sequence similarity with mouse interferon-β (<xref ref-type="bibr" rid="bib50">Tirone and Shooter, 1989</xref>). Our structure suggests that IFRD proteins regulate translation instead of, or in addition to, transcription.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.40486.007</object-id><label>Figure 3.</label><caption><title>IFRD2 binding to ribosomes is incompatible with translation.</title><p>(<bold>A</bold>) IFRD2 (interferon-related developmental regulator 2) occupies the intersubunit space in a subset of ribosomes containing Z-site tRNA. (<bold>B</bold>) Model of IFRD2 colored by domain. (<bold>C</bold>) IFRD2 interacts with many of the same ribosomal elements as P-site tRNA. (<bold>D</bold>) The C-terminal α-helix of IFRD2 occupies the mRNA exit channel and follows the path taken by mRNA through the ribosome. (<bold>E</bold>) 200 nM ribosomes isolated from rabbit reticulocyte lysate were treated without or with 50 μg/mL RNase A or 10 mM EDTA for 5 min and subjected to native size fractionation on 10 – 50% sucrose gradients. Eleven fractions taken from the top were collected and subjected to immunoblotting for IFRD2. Absorbance readings at 254 nm are shown below.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40486.008</object-id><label>Figure 3—figure supplement 1.</label><caption><title>IFRD2 interactions with 80S ribosomes.</title><p>(<bold>A</bold>) Fit of the IFRD2 model (teal) to the EM density map. (<bold>B</bold>) EM density corresponding to helix 8 of IFRD2, with corresponding residues of IFRD2 and aligned residues of IFRD1 (grey) indicated. (<bold>C</bold>) Comparison of interactions of P-site tRNA (green, left panel) and IFRD2 (right panel) with rRNA and proteins (uL13 and uL5) of the large ribosomal subunit. (<bold>D</bold>) Density of the C-terminal tail of IFRD2 (green), displaying interactions with 18S rRNA, uS11, and eS26 in the mRNA exit channel.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig3-figsupp1-v2"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40486.009</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Sequence alignment of IFRD family members of selected eukaryotes.</title><p>Alignment of IFRD family paralog sequences from multiple eukaryotes, with highly conserved residues highlighted in purple. Secondary structure corresponding to the atomic model of IFRD2, colored as in <xref ref-type="fig" rid="fig3">Figure 3</xref>, is shown above.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig3-figsupp2-v2"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.40486.010</object-id><label>Figure 3—figure supplement 3.</label><caption><title>Characteristics of IFRD2 association with mammalian ribosomes.</title><p>(<bold>A</bold>) Rabbit reticulocyte lysate was directly treated without or with 50 μg/mL RNase A for 5 min and subjected to size fractionation on a 10 – 50% sucrose gradient. Eleven fractions collected from the top of the gradient were analyzed by SDS-PAGE and immunoblotting for IFRD2. Migration of 80S ribosomes is indicated. Note that all detectable endogenous IFRD2 is in ribosomal fractions. (<bold>B</bold>) Ribosomes isolated from reticulocyte lysate and HEK293T cell lysate by centrifugation were directly analyzed by SDS-PAGE and immunoblotting for the indicated ribosomal proteins and IFRD2. Comparing 0.2 pmol of reticulocyte ribosomes (lane 1) with a serial twofold titration of HEK293T ribosomes reveals an enrichment of IFRD2 on the former. (<bold>C</bold>) HEK293T cells overexpressing Flag-tagged IFRD2 were lysed and directly analyzed as in (<bold>A</bold>) and immunoblotting against the Flag epitope. (<bold>D</bold>) Lysates from HEK293T cells overexpressing Flag-tagged IFRD2 were subject to affinity purification via the Flag epitope. The elution and 10% equivalent input were analyzed by SDS-PAGE, Ponceau staining (top) and immunoblotting for ribosomal proteins, revealing that IFRD2 copurifies with ribosomes. (<bold>E</bold>) Ribosomes (ribo.) in the elution in (<bold>D</bold>) were pelleted and subjected to native size fractionation on a 10–50% gradient without or with 10 mM EDTA. Eleven fractions from the top were collected and analyzed by SDS-PAGE and immunoblotting for Flag-tagged IFRD2. (<bold>F</bold>) Cryo-EM map of Flag-tagged IFRD2 on human 80S ribosomes, with the model of IFRD2 (<xref ref-type="fig" rid="fig3">Figure 3</xref>) docked.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig3-figsupp3-v2"/></fig></fig-group><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.40486.011</object-id><label>Table 1.</label><caption><title>Structurally distinct classes identified within a cryo-EM dataset of 971,191 ribosomal particles.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Ribosomal <break/>complex</th><th>Resolution (Å)</th><th>Particles</th><th>% of particles</th><th>EMDB <break/>accession code</th></tr></thead><tbody><tr><td colspan="4" valign="top">80S classes (unrotated)</td><td valign="top"/></tr><tr><td valign="top">80S • P</td><td valign="top">5.9</td><td valign="top">2101</td><td valign="top">0.2</td><td valign="top">9234</td></tr><tr><td valign="top">80S • P • E</td><td valign="top">3.8</td><td valign="top">23,945</td><td valign="top">2.5</td><td valign="top">9235</td></tr><tr><td valign="top">80S • P • E • eRF1 • ABCE1</td><td valign="top">3.6</td><td valign="top">83,682</td><td valign="top">8.6</td><td valign="top">-</td></tr><tr><td valign="top">80S • Z</td><td valign="top">4.2</td><td valign="top">10,783</td><td valign="top">1.1</td><td valign="top">9236</td></tr><tr><td valign="top">80S • Z • P</td><td valign="top">3.6</td><td valign="top">62,560</td><td valign="top">6.4</td><td valign="top">9237</td></tr><tr><td valign="top">80S • Z • IFRD2</td><td valign="top">3.4</td><td valign="top">74,031</td><td valign="top">7.6</td><td valign="top">9239</td></tr><tr><td valign="top">80S • eEF2 • SERBP1 <break/>(head swivel)</td><td valign="top">3.3</td><td valign="top">146,801</td><td valign="top">15.1</td><td valign="top">9240</td></tr><tr><td colspan="4" valign="top">80S classes (rotated)</td><td valign="top"/></tr><tr><td valign="top">80S • A/P • P/E</td><td valign="top">3.8</td><td valign="top">33,664</td><td valign="top">3.5</td><td valign="top">9241</td></tr><tr><td valign="top">80S • eEF2 • SERBP1</td><td valign="top">3.4</td><td valign="top">133,480</td><td valign="top">13.7</td><td valign="top">9242</td></tr></tbody></table></table-wrap><table-wrap id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.40486.013</object-id><label>Table 2.</label><caption><title>Model statistics.</title></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="center">80S • Z • P</th><th align="center">80S • Z • IFRD2</th><th align="center">80S • eEF2 • SERBP1 <break/>(head swivel)</th><th align="center">80S • eEF2 • SERBP1 <break/>(rotated)</th></tr></thead><tbody><tr><td valign="top">Model composition</td><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/></tr><tr><td valign="top"> Protein residues</td><td align="center" valign="top">11,547</td><td align="center" valign="top">11,901</td><td align="center" valign="top">12,760</td><td align="center" valign="top">12,591</td></tr><tr><td valign="top"> RNA bases (+modified bases)</td><td align="center" valign="top">5686 (40)</td><td align="center" valign="top">5603 (26)</td><td align="center" valign="top">5534 (36)</td><td align="center" valign="top">5528 (40)</td></tr><tr><td valign="top"> Ligands (Zn<sup>2+</sup>/Mg<sup>2+</sup>)</td><td align="center" valign="top">8/297</td><td align="center" valign="top">8/311</td><td align="center" valign="top">8/297</td><td align="center" valign="top">8/298</td></tr><tr><td valign="top">Refinement</td><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/></tr><tr><td valign="top"> Resolution (Å)</td><td align="center" valign="top">3.6</td><td align="center" valign="top">3.4</td><td align="center" valign="top">3.3</td><td align="center" valign="top">3.4</td></tr><tr><td valign="top"> Map sharpening B factor (Å<sup>2</sup>)</td><td align="center" valign="top">−101.9</td><td align="center" valign="top">−95.5</td><td align="center" valign="top">−97.1</td><td align="center" valign="top">−95.1</td></tr><tr><td valign="top"> Average B factor (Å<sup>2</sup>)</td><td align="center" valign="top">75.6</td><td align="center" valign="top">51.8</td><td align="center" valign="top">84.1</td><td align="center" valign="top">86.1</td></tr><tr><td valign="top"> Correlation coefficient volume mask</td><td align="center" valign="top">0.844 <break/>0.865</td><td align="center" valign="top">0.825 <break/>0.853</td><td align="center" valign="top">0.847 <break/>0.862</td><td align="center" valign="top">0.847 <break/>0.862</td></tr><tr><td valign="top">Rms deviations</td><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/></tr><tr><td valign="top"> Bond lengths (Å)</td><td align="center" valign="top">0.010</td><td align="center" valign="top">0.009</td><td align="center" valign="top">0.007</td><td align="center" valign="top">0.008</td></tr><tr><td valign="top"> Bond angles (°)</td><td align="center" valign="top">1.2</td><td align="center" valign="top">1.1</td><td align="center" valign="top">1.1</td><td align="center" valign="top">1.0</td></tr><tr><td valign="top">Validation (proteins)</td><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/></tr><tr><td valign="top"> MolProbity score</td><td align="center" valign="top">1.79</td><td align="center" valign="top">1.64</td><td align="center" valign="top">1.68</td><td align="center" valign="top">1.71</td></tr><tr><td valign="top"> Clashscore, all atoms</td><td align="center" valign="top">5.8</td><td align="center" valign="top">5.0</td><td align="center" valign="top">5.6</td><td align="center" valign="top">5.7</td></tr><tr><td valign="top"> Rotamer outliers (%)</td><td align="center" valign="top">1.3</td><td align="center" valign="top">0.8</td><td align="center" valign="top">0.9</td><td align="center" valign="top">0.9</td></tr><tr><td valign="top"> EMRinger score</td><td align="center" valign="top">2.87</td><td align="center" valign="top">3.24</td><td align="center" valign="top">2.86</td><td align="center" valign="top">2.97</td></tr><tr><td valign="top">Ramachandran plot</td><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/></tr><tr><td valign="top"> Favored (%)</td><td align="center" valign="top">94.0</td><td align="center" valign="top">94.3</td><td align="center" valign="top">94.5</td><td align="center" valign="top">94.0</td></tr><tr><td valign="top"> Outliers (%)</td><td align="center" valign="top">0.1</td><td align="center" valign="top">0.1</td><td align="center" valign="top">0.1</td><td align="center" valign="top">0.1</td></tr><tr><td valign="top"> Validation (RNA)</td><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/></tr><tr><td valign="top"> Probably wrong sugar puckers (%)</td><td align="center" valign="top">1.6</td><td align="center" valign="top">1.5</td><td align="center" valign="top">1.6</td><td align="center" valign="top">1.4</td></tr><tr><td valign="top"> Bad backbone conformations (%)</td><td align="center" valign="top">23.6</td><td align="center" valign="top">23.6</td><td align="center" valign="top">22.8</td><td align="center" valign="top">22.0</td></tr><tr><td valign="top"> PDB</td><td align="center" valign="top">6MTB</td><td align="center" valign="top">6MTC</td><td align="center" valign="top">6MTD</td><td align="center" valign="top">6MTE</td></tr></tbody></table></table-wrap><p>The core of IFRD2 (residues 71 – 342), which follows an unstructured N-terminus absent in our reconstruction, adopts an Armadillo-type fold formed by six HEAT repeats (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Each HEAT repeat contains two α-helices linked by a short loop that together form a curved α-solenoid. A small globular domain of IFRD2 (residues 343 – 400) binds the concave surface of the α-solenoid and contacts each repeat. These core domains occupy the same space as a P-site tRNA and interact with many of the same ribosomal elements (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). For example, an α-helix of IFRD2 (residues 375–384) contacts H69 of 28S rRNA at the same place as the D stem of a P-site tRNA, and IFRD2 interactions with uL5 and uL13 are reminiscent of those made by the P-site tRNA acceptor arm (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). IFRD2 also interacts with the ribosomal small subunit through a C-terminal tail containing an α-helix that protrudes into the mRNA exit channel (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). Its path through the channel follows that of mRNA: it starts at the P site, extends through the E site, and ends by contacting ribosomal proteins uS11 and eS26 at the channel exit. The α-helix forms multiple electrostatic interactions with the rRNA phosphate backbone that lines the channel via highly conserved residues (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), suggesting that other IFRD proteins bind the ribosome with a similar insertion.</p><p>These interactions indicate that IFRD2 engages non-translating ribosomes with vacant mRNA channels and precludes further translation. Although a previous large-scale mass spectrometry study suggested that the ribosomal interaction of IFRD1 and IFRD2 are sensitive to RNase treatment (<xref ref-type="bibr" rid="bib48">Simsek et al., 2017</xref>), treating reticulocyte lysate or ribosomes with RNase collapses mRNA-dependent polysomes but does not disrupt the stoichiometric association of endogenous IFRD2 with 80S ribosomes (<xref ref-type="fig" rid="fig3">Figure 3E</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>). This is consistent with our structure showing that IFRD2 binds to core ribosomal features independently of mRNA and tRNAs.</p><p>The observation that almost 8% of particles in the dataset contain IFRD2 suggests that it is highly abundant in reticulocytes. Indeed, IFRD2 appears to be ~8 fold less abundant on human HEK293T ribosomes compared to reticulocyte ribosomes (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>). Overexpressed Flag-tagged human IFRD2 in HEK293T cells also associates and copurifies with 80S ribosomes independent of RNase treatment (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C–E</xref>), further supporting the specific association of IFRD2 with ribosomes. We collected a small cryo-EM dataset of affinity purified IFRD2-containing ribosomes from HEK293T cells, which confirmed that IFRD2 binds human ribosomes identically as those observed in the reticulocyte sample (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3F</xref>).</p></sec><sec id="s2-4"><title>A new tRNA-binding site on the mammalian ribosome</title><p>All ribosomes bound to IFRD2 in the reticulocyte dataset also contain a tRNA in an extreme position on the ribosome past the E site that we call the ‘Z site’ (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Although we could not distinguish any IFRD2-containing reticulocyte ribosomes lacking Z-site tRNA, we do not observe Z-site tRNA in the reconstruction of IFRD2 on the human ribosome (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3F</xref>), indicating that Z-site tRNA is not required for IFRD2 binding. In the combined dataset of reticulocyte ribosomes, Z-site tRNA also binds 80S ribosomes alone and with peptidyl-tRNA (<xref ref-type="fig" rid="fig1">Figure 1</xref>) but would clash with an E-site tRNA (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.40486.012</object-id><label>Figure 4.</label><caption><title>Z-site tRNA.</title><p>(<bold>A</bold>) Position of Z-site tRNA on the ribosome in the presence of a P-site tRNA. Docked E-site tRNA (shown in cartoon representation) is incompatible with a Z-site tRNA. (<bold>B</bold>) Interactions between the Z-site tRNA (CCA nucleotides shown in stick representation) and the 60S ribosomal subunit. (<bold>C</bold>) Interaction between the anticodon stem-loop (anticodon nucleotides shown in stick representation) of Z-site tRNA and eS25. (<bold>D</bold>) Cryo-EM map of CrPV IRES (EMD-2599), with the L1.1 and stem-loop V (SLV) domains, which make similar interactions as Z-site tRNA, indicated, bound to the <italic>Kluyveromyces lactis</italic> ribosome. LSU – large ribosomal subunit; SSU – small ribosomal subunit; IRES – internal ribosome entry site; SLV – stem-loop V.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-40486-fig4-v2"/></fig><p>Like the universal tRNA-binding positions, Z-site tRNA bridges the ribosomal subunits. Three distinct interactions are observed between the tRNA and the large subunit. First, the backbone of the 3’ CCA binds a lysine-rich stretch of eL42 (residues 27 – 30) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Second, the acceptor arm binds the backbone of helix 68 of 28S rRNA (nucleotides 3730 – 3732), and third, the elbow of the Z-site tRNA interacts with the L1 stalk (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). At the head of the 40S subunit, the anticodon stem-loop of the Z-site tRNA binds a positively charged site on the non-essential ribosomal protein, eS25 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Although eS25 has not been shown to bind tRNAs previously, it is a common binding site for internal ribosome entry site (IRES) sequences utilized by many viruses, including human immunodeficiency virus (HIV) and the hepatitis C virus (<xref ref-type="bibr" rid="bib41">Quade et al., 2015</xref>; <xref ref-type="bibr" rid="bib61">Yamamoto et al., 2015</xref>), to initiate translation of viral RNA on host ribosomes. The Z-site tRNA most closely resembles the ribosome-binding conformation of the cricket paralysis virus (CPrV) IRES (<xref ref-type="bibr" rid="bib23">Fernández et al., 2014</xref>), which also bridges eS25 and the ribosomal L1 stalk (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Thus, viruses appear to exploit the Z site for IRES-mediated translation.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our structural analysis of reticulocyte ribosomes in a large cryo-EM dataset has revealed new insights into ribosome inactivation in mammals. We identify new similarities between yeast Stm1 and mammalian SERBP1, reveal the interactions that sequester eEF2 on the ribosome, and redefine the IFRD family as ribosome-silencing proteins.</p><p>As proposed for Stm1, IFRD2 may repress translation during cellular stress. Previous studies indicate that IFRD2 expression is induced in specific circumstances, such as tetradecanoyl phorbol acetate treatment and serum replenishment after starvation (<xref ref-type="bibr" rid="bib54">Varnum et al., 1989</xref>). In addition, IFRD proteins appear to escape translational repression by stress-induced eIF2α phosphorylation via an upstream open-reading frame (uORF) (<xref ref-type="bibr" rid="bib5">Andreev et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Zhao et al., 2010</xref>). IFRD proteins may also provide a general mechanism to reduce translational output, which may explain the pleiotropic effects of IFRD ablation on the differentiation of various cell types (<xref ref-type="bibr" rid="bib55">Vietor et al., 2002</xref>).</p><p>Our results suggest that IFRD2 is especially abundant on ribosomes in reticulocytes, the immediate precursors to red blood cells. Reticulocytes also express enhanced levels of other factors that can suppress protein synthesis, including the heme-dependent eIF2α kinase HRI (<xref ref-type="bibr" rid="bib16">Crosby et al., 1994</xref>). Considering the importance of ribosomal levels (<xref ref-type="bibr" rid="bib27">Khajuria et al., 2018</xref>) and global translational regulation (<xref ref-type="bibr" rid="bib25">Grevet et al., 2018</xref>) on red blood cell differentiation and function, IFRD2 may offer an additional layer of translational control to dictate blood cell fate.</p><p>While SERBP1 and IFRD2 may act redundantly to inactivate mammalian ribosomes, our structures suggest they target different subsets of ribosomes and may induce different fates. In yeast, Stm1-inactivated ribosomes are recycled after starvation by Dom34-Hbs1 (Pelota-Hbs1l in mammals) and Rli1 (ABCE1 in mammals) (<xref ref-type="bibr" rid="bib51">van den Elzen et al., 2014</xref>). Whether IFRD2-silenced ribosomes are similarly rescued, and the physiological conditions and timescales of these processes, remain to be determined. The regulation of these two mechanisms may impact their role on global translation activity during different types of cellular differentiation and stress.</p><p>We additionally observe Z-site tRNA on all reticulocyte ribosomes containing IFRD2. Although we cannot rule out the possibility that a tRNA in the Z site results from an artefact of isolating these samples, the stable association of Z-site tRNA and the similarity with IRES interactions supports the idea that the Z site is a preferred binding site for certain RNA structures, potentially including cellular mRNAs. In yeast, knocking out eS25, a key interacting partner of Z-site tRNA, decreases global protein synthesis and slows growth (<xref ref-type="bibr" rid="bib24">Ferreira-Cerca et al., 2005</xref>; <xref ref-type="bibr" rid="bib30">Landry et al., 2009</xref>). A recent study also suggests that eS25 is expressed at substoichiometric levels relative to total ribosomes in mammals, and that ribosomes containing eS25 may preferentially translate subsets of mRNAs (<xref ref-type="bibr" rid="bib47">Shi et al., 2017</xref>).</p><p>The Z-site may represent a late-stage intermediate of tRNA ejection downstream of the E site. This hypothesis is supported by the observation that Z-site tRNA can bind simultaneously with a P-site tRNA but not a canonical E-site tRNA, and that Z-site tRNA interacts with the L1 stalk, which interacts with all known tRNA-ejection intermediates in bacteria (<xref ref-type="bibr" rid="bib3">Agrawal et al., 2000</xref>) (<xref ref-type="bibr" rid="bib64">Zhang et al., 2018</xref>). However, the interaction of Z-site tRNA with the eukaryotic-specific proteins eL42 and eS25 suggests that the Z site is distinct from bacterial tRNA-ejection intermediates.</p><p>A Z-site tRNA ejection intermediate would be transient during active translation, occurring only before the next translocation event. Therefore, the presence of a stably bound Z-site tRNA could act as signature of a translationally incompetent ribosome regardless of whether it engages the Z site from the E site or from a pool of deacylated tRNAs in the cytosol. In this scenario, tRNA binding to the Z site is more likely when deacylated tRNA levels rise, for example by amino acid depletion, or when translational factors are limiting. Intriguingly, deacylated tRNAs, a yeast-specific tRNA ejection factor, and stalled ribosomes are all implicated in regulating the integrated stress response by the GCN2 kinase (<xref ref-type="bibr" rid="bib26">Ishimura et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Ramirez et al., 1991</xref>; <xref ref-type="bibr" rid="bib57">Visweswaraiah et al., 2012</xref>).</p><p>Our unexpected observation of IFRD2 and a new tRNA position on the mammalian ribosome highlights the ability of mining cryo-EM datasets to reveal new biological interactions from heterogeneous samples. This strategy is directly applicable to identifying and visualizing binding partners of other biological assemblies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Cell Line <break/>(<italic>H. sapiens</italic>)</td><td>HEK293T</td><td>American Type <break/>Culture Collection</td><td>Cat# CRL-3216 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0063">CVCL_0063</ext-link></td><td/></tr><tr><td>Recombinant <break/>DNA reagent</td><td>pcDNA3.1-3xFLAG-TEV-IFRD2</td><td>This paper</td><td>N/A</td><td>Mammalian expression vector expressing Flag-tagged IFRD2 behind a CMV promoter</td></tr><tr><td>Antibody</td><td>IFRD2</td><td>Invitrogen</td><td>Cat# PA5-48833 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2634289">AB_2634289</ext-link></td><td>IB: 1:1000</td></tr><tr><td>Antibody</td><td>FLAG M2</td><td>Sigma-Aldrich</td><td>Cat# F3165 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_259529">AB_259529</ext-link></td><td>IB: 1:5000</td></tr><tr><td>Antibody</td><td>uL2</td><td>Abcam</td><td>Cat# ab169538 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2714187">AB_2714187</ext-link></td><td>IB: 1:10000</td></tr><tr><td>Antibody</td><td>eS24</td><td>Abcam</td><td>Cat# ab196652 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB">AB</ext-link>)2714188</td><td>IB: 1:3000</td></tr><tr><td>Antibody</td><td>HRP anti-mouse</td><td>Jackson ImmunoResearch</td><td>Cat# 115-035-003 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10015289">AB_10015289</ext-link></td><td>IB: 1:5000</td></tr><tr><td>Antibody</td><td>HRP anti-rabbit</td><td>Jackson ImmunoResearch</td><td>Cat# 111-035-003 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2313567">AB_2313567</ext-link></td><td>IB: 1:5000</td></tr><tr><td>Antibody</td><td>FLAG M2 <break/>agarose resin</td><td>Sigma-Aldrich</td><td>Cat# A2220 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10063035">AB_10063035</ext-link></td><td/></tr><tr><td>Peptide, <break/>recombinant protein</td><td>3X FLAG peptide</td><td>Sigma-Aldrich</td><td>Cat# F4799</td><td/></tr><tr><td>Peptide, <break/>recombinant protein</td><td>RNase A</td><td>Sigma-Aldrich</td><td>Cat# R6513</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>Dulbecco's Modified Eagle Medium (DMEM)</td><td>Gibco/Thermo Fisher</td><td>Cat# 10569</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>HyClone Fetal <break/>Bovine Serum</td><td>GE Healthcare Life Sciences</td><td>Cat# SH30910.03</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>Trypsin-EDTA</td><td>Gibco/Thermo Fisher</td><td>Cat# 25200</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>OptiMEM</td><td>Gibco/Thermo Fisher</td><td>Cat# 31985</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>TransIT 293</td><td>Mirus</td><td>Cat# MIR2705</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>EDTA</td><td>GrowCells</td><td>Cat# MRGF-1202</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>SuperSignal <break/>West Pico</td><td>Thermo Fisher</td><td>Cat# 34080</td><td/></tr><tr><td>Biological <break/>sample (<italic>O. cuniculus</italic>)</td><td>Rabbit <break/>reticulocyte lysate</td><td>Green Hectares</td><td>N/A</td><td/></tr><tr><td>Software, <break/>algorithm</td><td>RELION-2.0 or <break/>RELION-2.1</td><td><xref ref-type="bibr" rid="bib28">Kimanius et al., 2016</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016274">SCR_016274</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://www2.mrc-lmb.cam.ac.uk/relion">https://www2.mrc-lmb.cam.ac.uk/relion</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>MotionCor2</td><td><xref ref-type="bibr" rid="bib66">Zheng et al., 2017</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016499">SCR_016499</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="http://msg.ucsf.edu/em/software/motioncor2.html">http://msg.ucsf.edu/em/software/motioncor2.html</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>GCTF</td><td><xref ref-type="bibr" rid="bib63">Zhang, 2016</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016500">SCR_016500</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://www.mrc-lmb.cam.ac.uk/kzhang/">https://www.mrc-lmb.cam.ac.uk/kzhang/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>UCSF Chimera</td><td><xref ref-type="bibr" rid="bib40">Pettersen et al., 2004</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004097">SCR_004097</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://www.cgl.ucsf.edu/chimera/">https://www.cgl.ucsf.edu/chimera/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>Coot v.0.8.9</td><td><xref ref-type="bibr" rid="bib11">Brown et al., 2015a</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014222">SCR_014222</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/">https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>I-TASSER</td><td><xref ref-type="bibr" rid="bib62">Zhang, 2008</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014627">SCR_014627</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://zhanglab.ccmb.med.umich.edu/I-TASSER/">https://zhanglab.ccmb.med.umich.edu/I-TASSER/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td valign="bottom">PHENIX</td><td><xref ref-type="bibr" rid="bib1">Adams et al., 2010</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014224">SCR_014224</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://www.phenix-online.org/">https://www.phenix-online.org/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>MolProbity v.4.3.1</td><td><xref ref-type="bibr" rid="bib14">Chen et al., 2010</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014226">SCR_014226</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="http://molprobity.biochem.duke.edu/">http://molprobity.biochem.duke.edu/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>EMRinger</td><td><xref ref-type="bibr" rid="bib9">Barad et al., 2015</xref></td><td valign="bottom">N/A</td><td><ext-link ext-link-type="uri" xlink:href="http://emringer.com/">http://emringer.com/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>SBGrid</td><td><xref ref-type="bibr" rid="bib35">Morin et al., 2013</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003511">SCR_003511</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://sbgrid.org/">https://sbgrid.org/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>PyMOL</td><td><xref ref-type="bibr" rid="bib19">DeLano, 2002</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_000305">SCR_000305</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="http://www.pymol.org">http://www.pymol.org</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>SCIPION</td><td><xref ref-type="bibr" rid="bib18">de la Rosa-Trevín et al., 2016</xref></td><td>N/A</td><td><ext-link ext-link-type="uri" xlink:href="http://scipion.i2pc.es/">http://scipion.i2pc.es/</ext-link></td></tr><tr><td>Software, <break/>algorithm</td><td>MonoRes</td><td><xref ref-type="bibr" rid="bib56">Vilas et al., 2018</xref></td><td>N/A</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Plasmids and antibodies</title><p>The ORF of IFRD2 was subcloned into a pcDNA3.1-based vector after a CMV promoter and an N-terminal 3X Flag tag and TEV cleavage site. IFRD2 antibody was obtained from Invitrogen (PA5-48833). Anti-FLAG M2 monoclonal antibody (F3165), resin (A2220) and 3X FLAG peptide (F4799) were obtained from Sigma-Aldrich.</p></sec><sec id="s4-2"><title>Mass spectrometry</title><p>Three samples for mass-spectrometry analysis were prepared to identify the proteins present in the samples used for cryo-EM (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The first was prepared exactly as for cryo-EM analysis (<xref ref-type="bibr" rid="bib12">Brown et al., 2015b</xref>). Briefly, we performed 2 mL in vitro translation reactions of a model substrate encoding an N-terminal 3X Flag tag, the autonomously folding villin headpiece domain, and the cytosolic portion of Sec61β in the presence of 0.5 μM dominant negative eRF1 in which the catalytic GGQ motif is mutated to AAQ to trap ribosomes at stop codons. Immediately after the translation reaction, we affinity purified the stalled ribosome-nascent protein complexes via the N-terminal 3X Flag tag on the nascent protein using anti-Flag M2 agarose beads (Sigma). The reactions were incubated with M2 affinity resin at 4°C for 1 hr, followed by three sequential 6 mL washes with: (1) 50 mM Hepes pH 7.4, 100 mM KOAc, 5 mM Mg(OAc)<sub>2</sub>, 0.1% Triton X-100, 1 mM DTT, (2) 50 mM Hepes pH 7.4, 250 mM KOAc, 5 mM Mg(OAc)<sub>2</sub>, 0.5% Triton X-100, 1 mM DTT, and (3) 50 mM Hepes pH 7.4, 100 mM KOAc, 5 mM Mg(OAc)<sub>2</sub>, 1 mM DTT. Two sequential elutions were performed with 0.1 mg/mL 3X Flag peptide in the third wash buffer for 25 min each at room temperature. This elution was directly analyzed as ‘sample A’ (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>To reduce the identification of ribosomal protein peptides, we evenly divided the elutions into two halves. We maintained one half in physiological salt concentrations and adjusted the other half to a final concentration of 750 mM KOAc, 15 mM Mg(OAc)<sub>2</sub>. We centrifuged both samples at 100,000 rpm for 30 min in a TLA120.2 rotor to pellet ribosomes and strip off peripherally associated proteins under the high-salt conditions. The supernatants from both spins were precipitated with trichloroacetic acid (TCA) and analyzed by SDS-PAGE and Coomassie staining. The entire gel lanes were excised and submitted for mass spectrometry analysis as ‘sample B’ (physiological salt wash) and ‘sample C’ (high-salt wash). The proteins identified by mass-spectrometry are given in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-3"><title>Cell, lysate, and ribosomal treatments</title><p>HEK293T cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) with high glucose and 10% fetal bovine serum and verified to be mycoplasma free. Transfections of Flag-tagged IFRD2 were performed when cells were 60 – 70% confluency using TransIT 293 (MIRUS) according to manufacturer instructions. 16 – 18 hr after transfection, we lysed cells in 50 mM Hepes pH 7.4, 100 mM KOAc, 5 mM Mg(OAc)<sub>2</sub>, 0.5% Triton X-100, 1 mM DTT, and protease inhibitor cocktail. Lysates were clarified by spinning at 20,000xg at 4°C for 10 min before being subjected to biochemical treatments.</p><p>Where applicable, rabbit reticulocyte lysate (Green Hectares; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>), 200 nM ribosomes (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) isolated from reticulocytes or HEK293T cell lysate (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>) were treated with 50 μg/mL RNase A at 25°C for 5 min before sucrose gradients. RNase A efficiency was confirmed after sucrose gradients by measuring absorbance at 254 nm to confirm the collapse of polysomes into monosome fractions (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). EDTA was included with ribosomes isolated from reticulocytes (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) or ribosomes pelleted after Flag-tagged IFRD2 affinity purification (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3E</xref>) at a final concentration 10 mM. All size fractionation were performed using 200 μL 10–50% sucrose gradients prepared in 50 mM Hepes pH 7.4, 100 mM KOAc, 5 mM Mg(OAc)<sub>2</sub> without or with 10 mM EDTA.</p><p>Samples were layered on top of the gradients and spun at 55,000 rpm using a TLS-55 rotor in an OptimaMax ultracentrifuge (Beckman Coulter) for 30 min at 4°C using the slowest acceleration and deceleration settings. Eleven 20 μL fractions were manually collected from the top for immunoblotting analysis.</p></sec><sec id="s4-4"><title>Affinity purification and cryo-EM analysis of human IFRD2-80S ribosome complexes</title><p>Four 10 cm plates of HEK293T cells were transfected as described above and passaged 1:4 the day after transfection. Two days later, the cells were lysed as described above and incubated with M2 anti-Flag agarose resin for 1 hr at 4°C. The resin was washed with 6 mL of lysis buffer and subjected to two sequential elutions using one column volume of 0.1 mg/mL 3X Flag peptide incubated at room temperature for 25 min. A portion of the elution was directly frozen onto cryo-EM grids, and the leftover elution was pelleted at 100,000 rpm for 40 min at 4°C in a TLA120.2 rotor to isolate ribosomes, which were subjected to biochemical analysis (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3E</xref>).</p><p>For cryo-EM analysis, 3 μL of the pooled elution containing ~80 nM ribosomes were directly frozen onto glow-discharged Quantifoil Cu R2/2 grids with a thin (~50 Å) continuous layer of carbon using a Vitrobot Mark III at 4°C and 100% humidity with 30 s wait time and 3 s blot time. A dataset of 877 micrographs was collected using an automated data collection pipeline in SerialEM on a Talos Arctica operated at 200 kV. Images were acquired at a nominal magnification of 36,000x (corresponding to a pixel size of 1.169 Å) with a Gatan K2 direct electron detector in super-resolution mode and defocus values ranging from −1.3 to −3 μm. Each movie was acquired at 5 frames/s over a total exposure time of 8 s and a dose rate of 5.4 electrons/pixel/s.</p></sec><sec id="s4-5"><title>Data processing</title><p>To take advantage of recent developments in cryo-EM image processing, we reprocessed datasets of ribosomes isolated in the presence of a dominant-negative eukaryotic release factor (DN-eRF1) (<xref ref-type="bibr" rid="bib12">Brown et al., 2015b</xref>). All processing steps were performed within RELION-2.0 or RELION-2.1 (<xref ref-type="bibr" rid="bib28">Kimanius et al., 2016</xref>). We used MotionCor2 (<xref ref-type="bibr" rid="bib66">Zheng et al., 2017</xref>) to correct for global and local (5 × 5 patches) beam-induced motion and to dose weight the individual frames. The motion-corrected sums without dose weighting were used for CTF estimation with GCTF (<xref ref-type="bibr" rid="bib63">Zhang, 2016</xref>). All motion- and CTF-corrected micrographs and their Fourier transforms were inspected manually to remove those that displayed astigmatism or ice contamination.</p><p>To generate reference templates for auto-picking, 2000 ribosomal particles were picked manually and subjected to 2D classification. The best five classes (out of 10) were low-pass filtered to 20 Å and used for auto-picking in RELION (<xref ref-type="bibr" rid="bib45">Scheres, 2015</xref>). For autopicking, a mask diameter of 360 Å and a minimum interparticle distance of 200 Å was used. The autopicked particles were extracted with a box size of 400 pixels and sorted by a Z-score generated by subtracting the reference image from the extracted particles. The sorted particles were inspected manually and non-ribosomal particles with a low Z score discarded. Retained particles were subjected to reference-free 2D classification and the best-resolved classes selected. In total, 971,191 particles were retained after 2D classification.</p><p>All selected particles were subjected to an initial round of refinement using RELION’s 3D autorefine in which a 30 Å low-pass filtered map of the rabbit 80S ribosome with tRNAs but no factors (EMD-4129) (<xref ref-type="bibr" rid="bib46">Shao et al., 2016</xref>) was used as a reference. Following refinement, a single round of three-dimensional classification without alignment was performed. This strategy was very effective at separating rotated and unrotated 80S ribosomes from 60S ribosomal subunits.</p><p>To isolate particles corresponding to different classes within the set of 80S particles we used multiple rounds of focused classification with signal subtraction (FCwSS) (<xref ref-type="bibr" rid="bib7">Bai et al., 2015</xref>) centered on the A, P, E, and Z sites of the ribosome. These sites were chosen as they displayed nebulous density after the initial round of refinement, consistent with mixed occupancy. The use of FCwSS in classifying the data represents the most significant difference from how the maps were processed originally (<xref ref-type="bibr" rid="bib12">Brown et al., 2015b</xref>).</p><p>Once a defined class had been isolated, the particles were realigned, and the resultant maps postprocessed in RELION. For post-processing, solvent masks were generated using relion_mask_create. Typically, these binary masks were generated from the final map from refinement low-pass filtered to 15 Å at a threshold of 0.015 or 0.02. The initial binary mask was extended by 4 Å in all directions and a raised-cosine edge was added to create a soft mask. During post-processing, phase-randomization was used to correct for the convolution effects of the solvent mask. Overall resolution estimates were calculated from Fourier shell correlations at 0.143 between the two independently refined half-maps. Final reconstructions were sharpened using automatically estimated B-factors (<xref ref-type="bibr" rid="bib43">Rosenthal and Henderson, 2003</xref>).</p><p>Processing of the human IFRD2-80S ribosomal complex was performed in RELION 2.1 as described above. After 2D classification, 22,807 particles were subject to an initial refinement using EMD-4129 low-pass filtered to 40 Å as a reference. We used the refined map, which already had clear IFRD2 density, as a reference for 3D classification to isolate 80S ribosomes, followed by a round of FCwSS centered on IFRD2 density. A final refinement of 5714 particles resulted in an 8.3 Å map without postprocessing.</p></sec><sec id="s4-6"><title>Model building and refinement</title><p>Our 3.6 Å map of 80S•eRF1•ABCE1 complex was used as the starting point for model building. The model of the rabbit 80S ribosome in an unrotated state (PDB accession code 5LZV) (<xref ref-type="bibr" rid="bib46">Shao et al., 2016</xref>) was fitted into this map using the ‘fit in map’ feature of Chimera (<xref ref-type="bibr" rid="bib40">Pettersen et al., 2004</xref>). All non-ribosomal elements were deleted, and chemical modifications added to ribosomal RNA and proteins uL4 and eL40 using the cryo-EM structure of the human ribosome as a guide (<xref ref-type="bibr" rid="bib37">Natchiar et al., 2017</xref>). This model was propagated to all other maps as individual 60S and 40S subunits. For the rotated and head-swiveled classes, the individual proteins and rRNA in the head of the 40S subunit were fitted as rigid bodies following docking of the ribosomal subunits.</p><p>Protein factors and tRNAs were modeled in Coot v0.8.9 (<xref ref-type="bibr" rid="bib11">Brown et al., 2015a</xref>). P- and E-site tRNAs were extracted from the rabbit 80S ribosome (PDB accession code 5LZV) (<xref ref-type="bibr" rid="bib46">Shao et al., 2016</xref>). The Z-site tRNA was modeled using the same sequence as for the E-site tRNA, although the density comes from a mixture of different tRNAs. The model for the L1 stalk was built using the crystal structure of the L1-stalk fragment from <italic>Haloarcula marismortui</italic> (PDB accession code 5Ml7) as a template. The rabbit L1 protein (NCBI ID: XP_002714675) was modeled by docking a comparative model generated using I-TASSER (<xref ref-type="bibr" rid="bib62">Zhang, 2008</xref>) and morphing it to fit the density using Phenix.real_space_refinement (<xref ref-type="bibr" rid="bib2">Afonine et al., 2018</xref>). The model for IFRD2 (NCBI XP_002713258) was built de novo from polyalanine helices placed into the map. Sequences were assigned to these helices based on side chain density and the helices connected by manual model building in Coot. eEF2 was modeled using the model of <italic>Sus scrofa</italic> eEF2 (PDB accession code 3J7P) (<xref ref-type="bibr" rid="bib58">Voorhees et al., 2014</xref>) as a template. Human numbering and sequence (Uniprot ID: P13639) was used as sequence information is not available for rabbit eEF2. SERBP1 isoform X2 (XP_002715981) was built de novo into the density.</p><p>All models were refined using Phenix.real_space_refinement v1.13_2998 (<xref ref-type="bibr" rid="bib2">Afonine et al., 2018</xref>). Each round of global real-space refinement featured five macro-cycles with secondary structure, rotamer, Ramachandran, and Cβ-torsion restraints applied. Secondary structure restraints were determined directly from the model and recalculated for each round of refinement. For the rRNA and tRNAs present in the models, hydrogen-bonding and base-pair and stacking parallelity restraints were applied. Additional restraints were applied for the chemical modifications of the ribosome and the diphthamide modification of eEF2. These restraints were generated using phenix.readyset. The high-resolution limit was set during refinement to match the nominal resolution obtained by postprocessing in Relion.</p><p>The final models were validated using MolProbity v.4.3.1 (<xref ref-type="bibr" rid="bib14">Chen et al., 2010</xref>) and EMRinger (<xref ref-type="bibr" rid="bib9">Barad et al., 2015</xref>), with final statistics given in table S2. Over-fitting was monitored using cross-validation (<xref ref-type="bibr" rid="bib4">Amunts et al., 2014</xref>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>Software used in the project were installed and configured by SBGrid (<xref ref-type="bibr" rid="bib35">Morin et al., 2013</xref>).</p></sec><sec id="s4-7"><title>Figures</title><p>Figure panels were generated using PyMOL (<xref ref-type="bibr" rid="bib19">DeLano, 2002</xref>) or Chimera (<xref ref-type="bibr" rid="bib40">Pettersen et al., 2004</xref>). Maps colored by local resolution were generated with unsharpened density maps using MonoRes (<xref ref-type="bibr" rid="bib56">Vilas et al., 2018</xref>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements </title><p>The authors thank V Ramakrishnan and RS Hegde, M Skehel and the MRC-LMB mass-spectrometry facility, Harvard Research Computing and SBGrid for computing support, E Fischer and SHarrison for access to their GPU workstations, the cryo-EM facility at the University of Massachusetts Worcester for help with cryo-EM data collection, L Hollingsworth and T Rapoport for comments, the Shao lab for helpful discussions, and NVIDIA Corporation for the donation of a Quadro P6000 GPU. This work was supported by Harvard Medical School, the International Retinal Research Foundation, the E Matilda Ziegler Foundation, the Richard and Susan Smith Family Foundation, and the Charles H Hood Foundation.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Supervision, Investigation, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Investigation, Writing—original draft, Writing—review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.40486.014</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-40486-transrepform-v2.docx"/></supplementary-material><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.40486.015</object-id><label>Supplementary file 1.</label><caption><title>Curated list of the proteins observed by mass spectrometry used to identify factors in the cryo-EM maps.</title><p>For clarity, ribosomal proteins and contaminating bacterial and skin proteins are excluded and known components of multisubunit complexes clustered at the end of the table. Sample A represents the sample used for cryo-EM. Sample B are the proteins eluted from ribosomes under physiological salt conditions. Sample C are the proteins eluted from ribosomes under high-salt (750 mM KOAc, 15 mM Mg(OAc)<sub>2</sub>) conditions. Proteins observed in cryo-EM complexes are highlighted in yellow.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-40486-supp1-v2.xlsx"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All cryo-EM maps and models have been deposited in EMDB under accession codes 9234, 9235, 9236, 9237, 9239, 9240, 9241 and 9242. All models have been deposited in PDB under accession codes 6MTB, 6MTC, 6MTD and 6MTE.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with a P-site tRNA (unrotated state)</data-title><source>EMBL-EBI Protein Data Bank</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-9234">EMD-9234</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with a P- and E-site tRNA</data-title><source>EMBL-EBI Protein Data Bank</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-9235">EMD-9235</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with a Z-site tRNA (unrotated state)</data-title><source>EMBL-EBI Protein Data Bank</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-9236">EMD-9236</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with P- and Z-site tRNAs (unrotated state)</data-title><source>EMBL-EBI Protein Data Bank</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-9237">EMD-9237</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with Z-site tRNA and IFRD2 (unrotated state)</data-title><source>EMBL-EBI Protein Data Bank</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-9239">EMD-9239</pub-id></element-citation></p><p><element-citation id="dataset6" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with eEF2 and SERBP1 (unrotated state with 40S head swivel)</data-title><source>EMBL-EBI Protein Data Bank</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-9240">EMD-9240</pub-id></element-citation></p><p><element-citation id="dataset7" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with A/P and P/E tRNAs (rotated state)</data-title><source>EMBL-EBI Protein Data Bank</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-9241">EMD-9241</pub-id></element-citation></p><p><element-citation id="dataset8" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with eEF2 and SERBP1 (rotated state)</data-title><source>EMBL-EBI Protein Data Bank</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pdbe/entry/emdb/EMD-9242">EMD-9242</pub-id></element-citation></p><p><element-citation id="dataset9" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with P- and Z-site tRNAs (unrotated state)</data-title><source>RCSB Protein Data Bank</source><pub-id assigning-authority="RCSB" pub-id-type="accession" xlink:href="http://www.rcsb.org/pdb/explore/explore.do?structureId=6MTB">6MTB</pub-id></element-citation></p><p><element-citation id="dataset10" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with Z-site tRNA and IFRD2 (unrotated state)</data-title><source>RCSB Protein Data Bank</source><pub-id assigning-authority="RCSB" pub-id-type="accession" xlink:href="http://www.rcsb.org/pdb/explore/explore.do?structureId=6MTC">6MTC</pub-id></element-citation></p><p><element-citation id="dataset11" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with eEF2 and SERBP1 (unrotated state with 40S head swivel)</data-title><source>RCSB Protein Data Bank</source><pub-id assigning-authority="RCSB" pub-id-type="accession" xlink:href="http://www.rcsb.org/pdb/explore/explore.do?structureId=6MTD">6MTD</pub-id></element-citation></p><p><element-citation id="dataset12" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>MR</given-names></name><name><surname>Yip</surname><given-names>MCJ</given-names></name><name><surname>Murray</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Rabbit 80S ribosome with eEF2 and SERBP1 (rotated state)</data-title><source>RCSB Protein Data Bank</source><pub-id assigning-authority="RCSB" pub-id-type="accession" xlink:href="http://www.rcsb.org/pdb/explore/explore.do?structureId=6MTE">6MTE</pub-id></element-citation></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>PD</given-names></name><name><surname>Afonine</surname> <given-names>PV</given-names></name><name><surname>Bunkóczi</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>VB</given-names></name><name><surname>Davis</surname> <given-names>IW</given-names></name><name><surname>Echols</surname> <given-names>N</given-names></name><name><surname>Headd</surname> <given-names>JJ</given-names></name><name><surname>Hung</surname> <given-names>LW</given-names></name><name><surname>Kapral</surname> <given-names>GJ</given-names></name><name><surname>Grosse-Kunstleve</surname> <given-names>RW</given-names></name><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Moriarty</surname> <given-names>NW</given-names></name><name><surname>Oeffner</surname> <given-names>R</given-names></name><name><surname>Read</surname> <given-names>RJ</given-names></name><name><surname>Richardson</surname> <given-names>DC</given-names></name><name><surname>Richardson</surname> <given-names>JS</given-names></name><name><surname>Terwilliger</surname> <given-names>TC</given-names></name><name><surname>Zwart</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title><italic>PHENIX</italic>: a comprehensive Python-based system for macromolecular structure solution</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id><pub-id pub-id-type="pmid">20124702</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afonine</surname> <given-names>PV</given-names></name><name><surname>Poon</surname> <given-names>BK</given-names></name><name><surname>Read</surname> <given-names>RJ</given-names></name><name><surname>Sobolev</surname> <given-names>OV</given-names></name><name><surname>Terwilliger</surname> <given-names>TC</given-names></name><name><surname>Urzhumtsev</surname> <given-names>A</given-names></name><name><surname>Adams</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Real-space refinement in Phenix for cryo-EM and crystallography</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/249607</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname> <given-names>RK</given-names></name><name><surname>Spahn</surname> <given-names>CM</given-names></name><name><surname>Penczek</surname> <given-names>P</given-names></name><name><surname>Grassucci</surname> <given-names>RA</given-names></name><name><surname>Nierhaus</surname> <given-names>KH</given-names></name><name><surname>Frank</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Visualization of tRNA movements on the <italic>Escherichia coli</italic> 70S ribosome during the elongation cycle</article-title><source>The Journal of Cell Biology</source><volume>150</volume><fpage>447</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1083/jcb.150.3.447</pub-id><pub-id pub-id-type="pmid">10931859</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amunts</surname> <given-names>A</given-names></name><name><surname>Brown</surname> <given-names>A</given-names></name><name><surname>Bai</surname> <given-names>XC</given-names></name><name><surname>Llácer</surname> <given-names>JL</given-names></name><name><surname>Hussain</surname> <given-names>T</given-names></name><name><surname>Emsley</surname> <given-names>P</given-names></name><name><surname>Long</surname> <given-names>F</given-names></name><name><surname>Murshudov</surname> <given-names>G</given-names></name><name><surname>Scheres</surname> <given-names>SHW</given-names></name><name><surname>Ramakrishnan</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Structure of the yeast mitochondrial large ribosomal subunit</article-title><source>Science</source><volume>343</volume><fpage>1485</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1126/science.1249410</pub-id><pub-id pub-id-type="pmid">24675956</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreev</surname> <given-names>DE</given-names></name><name><surname>O'Connor</surname> <given-names>PB</given-names></name><name><surname>Fahey</surname> <given-names>C</given-names></name><name><surname>Kenny</surname> <given-names>EM</given-names></name><name><surname>Terenin</surname> <given-names>IM</given-names></name><name><surname>Dmitriev</surname> <given-names>SE</given-names></name><name><surname>Cormican</surname> <given-names>P</given-names></name><name><surname>Morris</surname> <given-names>DW</given-names></name><name><surname>Shatsky</surname> <given-names>IN</given-names></name><name><surname>Baranov</surname> <given-names>PV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Translation of 5' leaders is pervasive in genes resistant to eIF2 repression</article-title><source>eLife</source><volume>4</volume><elocation-id>e03971</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.03971</pub-id><pub-id pub-id-type="pmid">25621764</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anger</surname> <given-names>AM</given-names></name><name><surname>Armache</surname> <given-names>JP</given-names></name><name><surname>Berninghausen</surname> <given-names>O</given-names></name><name><surname>Habeck</surname> <given-names>M</given-names></name><name><surname>Subklewe</surname> <given-names>M</given-names></name><name><surname>Wilson</surname> <given-names>DN</given-names></name><name><surname>Beckmann</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structures of the human and Drosophila 80S ribosome</article-title><source>Nature</source><volume>497</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/nature12104</pub-id><pub-id pub-id-type="pmid">23636399</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname> <given-names>XC</given-names></name><name><surname>Rajendra</surname> <given-names>E</given-names></name><name><surname>Yang</surname> <given-names>G</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Scheres</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sampling the conformational space of the catalytic subunit of human γ-secretase</article-title><source>eLife</source><volume>4</volume><elocation-id>e11182</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.11182</pub-id><pub-id pub-id-type="pmid">26623517</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balagopal</surname> <given-names>V</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Stm1 modulates translation after 80S formation in Saccharomyces cerevisiae</article-title><source>RNA</source><volume>17</volume><fpage>835</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1261/rna.2677311</pub-id><pub-id pub-id-type="pmid">21460238</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barad</surname> <given-names>BA</given-names></name><name><surname>Echols</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>RY</given-names></name><name><surname>Cheng</surname> <given-names>Y</given-names></name><name><surname>DiMaio</surname> <given-names>F</given-names></name><name><surname>Adams</surname> <given-names>PD</given-names></name><name><surname>Fraser</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy</article-title><source>Nature Methods</source><volume>12</volume><fpage>943</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3541</pub-id><pub-id pub-id-type="pmid">26280328</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Shem</surname> <given-names>A</given-names></name><name><surname>Garreau de Loubresse</surname> <given-names>N</given-names></name><name><surname>Melnikov</surname> <given-names>S</given-names></name><name><surname>Jenner</surname> <given-names>L</given-names></name><name><surname>Yusupova</surname> <given-names>G</given-names></name><name><surname>Yusupov</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The structure of the eukaryotic ribosome at 3.0 Å resolution</article-title><source>Science</source><volume>334</volume><fpage>1524</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1126/science.1212642</pub-id><pub-id pub-id-type="pmid">22096102</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>A</given-names></name><name><surname>Long</surname> <given-names>F</given-names></name><name><surname>Nicholls</surname> <given-names>RA</given-names></name><name><surname>Toots</surname> <given-names>J</given-names></name><name><surname>Emsley</surname> <given-names>P</given-names></name><name><surname>Murshudov</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>71</volume><fpage>136</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1107/S1399004714021683</pub-id><pub-id pub-id-type="pmid">25615868</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>A</given-names></name><name><surname>Shao</surname> <given-names>S</given-names></name><name><surname>Murray</surname> <given-names>J</given-names></name><name><surname>Hegde</surname> <given-names>RS</given-names></name><name><surname>Ramakrishnan</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Structural basis for stop codon recognition in eukaryotes</article-title><source>Nature</source><volume>524</volume><fpage>493</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/nature14896</pub-id><pub-id pub-id-type="pmid">26245381</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buszczak</surname> <given-names>M</given-names></name><name><surname>Signer</surname> <given-names>RA</given-names></name><name><surname>Morrison</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cellular differences in protein synthesis regulate tissue homeostasis</article-title><source>Cell</source><volume>159</volume><fpage>242</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.09.016</pub-id><pub-id pub-id-type="pmid">25303523</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>VB</given-names></name><name><surname>Arendall</surname> <given-names>WB</given-names></name><name><surname>Headd</surname> <given-names>JJ</given-names></name><name><surname>Keedy</surname> <given-names>DA</given-names></name><name><surname>Immormino</surname> <given-names>RM</given-names></name><name><surname>Kapral</surname> <given-names>GJ</given-names></name><name><surname>Murray</surname> <given-names>LW</given-names></name><name><surname>Richardson</surname> <given-names>JS</given-names></name><name><surname>Richardson</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title><italic>MolProbity</italic>: all-atom structure validation for macromolecular crystallography</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1107/S0907444909042073</pub-id><pub-id pub-id-type="pmid">20057044</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Translational control by heme-regulated eIF2α kinase during erythropoiesis</article-title><source>Current Opinion in Hematology</source><volume>21</volume><fpage>172</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1097/MOH.0000000000000030</pub-id><pub-id pub-id-type="pmid">24714526</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crosby</surname> <given-names>JS</given-names></name><name><surname>Lee</surname> <given-names>K</given-names></name><name><surname>London</surname> <given-names>IM</given-names></name><name><surname>Chen</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Erythroid expression of the heme-regulated eIF-2 alpha kinase</article-title><source>Molecular and Cellular Biology</source><volume>14</volume><fpage>3906</fpage><lpage>3914</lpage><pub-id pub-id-type="doi">10.1128/MCB.14.6.3906</pub-id><pub-id pub-id-type="pmid">7910943</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Keersmaecker</surname> <given-names>K</given-names></name><name><surname>Atak</surname> <given-names>ZK</given-names></name><name><surname>Li</surname> <given-names>N</given-names></name><name><surname>Vicente</surname> <given-names>C</given-names></name><name><surname>Patchett</surname> <given-names>S</given-names></name><name><surname>Girardi</surname> <given-names>T</given-names></name><name><surname>Gianfelici</surname> <given-names>V</given-names></name><name><surname>Geerdens</surname> <given-names>E</given-names></name><name><surname>Clappier</surname> <given-names>E</given-names></name><name><surname>Porcu</surname> <given-names>M</given-names></name><name><surname>Lahortiga</surname> <given-names>I</given-names></name><name><surname>Lucà</surname> <given-names>R</given-names></name><name><surname>Yan</surname> <given-names>J</given-names></name><name><surname>Hulselmans</surname> <given-names>G</given-names></name><name><surname>Vranckx</surname> <given-names>H</given-names></name><name><surname>Vandepoel</surname> <given-names>R</given-names></name><name><surname>Sweron</surname> <given-names>B</given-names></name><name><surname>Jacobs</surname> <given-names>K</given-names></name><name><surname>Mentens</surname> <given-names>N</given-names></name><name><surname>Wlodarska</surname> <given-names>I</given-names></name><name><surname>Cauwelier</surname> <given-names>B</given-names></name><name><surname>Cloos</surname> <given-names>J</given-names></name><name><surname>Soulier</surname> <given-names>J</given-names></name><name><surname>Uyttebroeck</surname> <given-names>A</given-names></name><name><surname>Bagni</surname> <given-names>C</given-names></name><name><surname>Hassan</surname> <given-names>BA</given-names></name><name><surname>Vandenberghe</surname> <given-names>P</given-names></name><name><surname>Johnson</surname> <given-names>AW</given-names></name><name><surname>Aerts</surname> <given-names>S</given-names></name><name><surname>Cools</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia</article-title><source>Nature Genetics</source><volume>45</volume><fpage>186</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/ng.2508</pub-id><pub-id pub-id-type="pmid">23263491</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Rosa-Trevín</surname> <given-names>JM</given-names></name><name><surname>Quintana</surname> <given-names>A</given-names></name><name><surname>Del Cano</surname> <given-names>L</given-names></name><name><surname>Zaldívar</surname> <given-names>A</given-names></name><name><surname>Foche</surname> <given-names>I</given-names></name><name><surname>Gutiérrez</surname> <given-names>J</given-names></name><name><surname>Gómez-Blanco</surname> <given-names>J</given-names></name><name><surname>Burguet-Castell</surname> <given-names>J</given-names></name><name><surname>Cuenca-Alba</surname> <given-names>J</given-names></name><name><surname>Abrishami</surname> <given-names>V</given-names></name><name><surname>Vargas</surname> <given-names>J</given-names></name><name><surname>Otón</surname> <given-names>J</given-names></name><name><surname>Sharov</surname> <given-names>G</given-names></name><name><surname>Vilas</surname> <given-names>JL</given-names></name><name><surname>Navas</surname> <given-names>J</given-names></name><name><surname>Conesa</surname> <given-names>P</given-names></name><name><surname>Kazemi</surname> <given-names>M</given-names></name><name><surname>Marabini</surname> <given-names>R</given-names></name><name><surname>Sorzano</surname> <given-names>CO</given-names></name><name><surname>Carazo</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Scipion: a software framework toward integration, reproducibility and validation in 3D electron microscopy</article-title><source>Journal of Structural Biology</source><volume>195</volume><fpage>93</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2016.04.010</pub-id><pub-id pub-id-type="pmid">27108186</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>DeLano</surname> <given-names>WL</given-names></name></person-group><year iso-8601-date="2002">2002</year><source>The PyMOL Molecular Graphics System</source><publisher-name>Springer Open</publisher-name></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draptchinskaia</surname> <given-names>N</given-names></name><name><surname>Gustavsson</surname> <given-names>P</given-names></name><name><surname>Andersson</surname> <given-names>B</given-names></name><name><surname>Pettersson</surname> <given-names>M</given-names></name><name><surname>Willig</surname> <given-names>TN</given-names></name><name><surname>Dianzani</surname> <given-names>I</given-names></name><name><surname>Ball</surname> <given-names>S</given-names></name><name><surname>Tchernia</surname> <given-names>G</given-names></name><name><surname>Klar</surname> <given-names>J</given-names></name><name><surname>Matsson</surname> <given-names>H</given-names></name><name><surname>Tentler</surname> <given-names>D</given-names></name><name><surname>Mohandas</surname> <given-names>N</given-names></name><name><surname>Carlsson</surname> <given-names>B</given-names></name><name><surname>Dahl</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia</article-title><source>Nature Genetics</source><volume>21</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/5951</pub-id><pub-id pub-id-type="pmid">9988267</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzierzak</surname> <given-names>E</given-names></name><name><surname>Philipsen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Erythropoiesis: development and differentiation</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>3</volume><elocation-id>a011601</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a011601</pub-id><pub-id pub-id-type="pmid">23545573</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname> <given-names>BL</given-names></name><name><surname>Pretz</surname> <given-names>J</given-names></name><name><surname>Bosco</surname> <given-names>J</given-names></name><name><surname>Chang</surname> <given-names>CY</given-names></name><name><surname>Tamayo</surname> <given-names>P</given-names></name><name><surname>Galili</surname> <given-names>N</given-names></name><name><surname>Raza</surname> <given-names>A</given-names></name><name><surname>Root</surname> <given-names>DE</given-names></name><name><surname>Attar</surname> <given-names>E</given-names></name><name><surname>Ellis</surname> <given-names>SR</given-names></name><name><surname>Golub</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification of RPS14 as a 5q- syndrome gene by RNA interference screen</article-title><source>Nature</source><volume>451</volume><fpage>335</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1038/nature06494</pub-id><pub-id pub-id-type="pmid">18202658</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández</surname> <given-names>IS</given-names></name><name><surname>Bai</surname> <given-names>XC</given-names></name><name><surname>Murshudov</surname> <given-names>G</given-names></name><name><surname>Scheres</surname> <given-names>SH</given-names></name><name><surname>Ramakrishnan</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Initiation of translation by cricket paralysis virus IRES requires its translocation in the ribosome</article-title><source>Cell</source><volume>157</volume><fpage>823</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.04.015</pub-id><pub-id pub-id-type="pmid">24792965</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-Cerca</surname> <given-names>S</given-names></name><name><surname>Pöll</surname> <given-names>G</given-names></name><name><surname>Gleizes</surname> <given-names>PE</given-names></name><name><surname>Tschochner</surname> <given-names>H</given-names></name><name><surname>Milkereit</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Roles of eukaryotic ribosomal proteins in maturation and transport of pre-18S rRNA and ribosome function</article-title><source>Molecular Cell</source><volume>20</volume><fpage>263</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.09.005</pub-id><pub-id pub-id-type="pmid">16246728</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grevet</surname> <given-names>JD</given-names></name><name><surname>Lan</surname> <given-names>X</given-names></name><name><surname>Hamagami</surname> <given-names>N</given-names></name><name><surname>Edwards</surname> <given-names>CR</given-names></name><name><surname>Sankaranarayanan</surname> <given-names>L</given-names></name><name><surname>Ji</surname> <given-names>X</given-names></name><name><surname>Bhardwaj</surname> <given-names>SK</given-names></name><name><surname>Face</surname> <given-names>CJ</given-names></name><name><surname>Posocco</surname> <given-names>DF</given-names></name><name><surname>Abdulmalik</surname> <given-names>O</given-names></name><name><surname>Keller</surname> <given-names>CA</given-names></name><name><surname>Giardine</surname> <given-names>B</given-names></name><name><surname>Sidoli</surname> <given-names>S</given-names></name><name><surname>Garcia</surname> <given-names>BA</given-names></name><name><surname>Chou</surname> <given-names>ST</given-names></name><name><surname>Liebhaber</surname> <given-names>SA</given-names></name><name><surname>Hardison</surname> <given-names>RC</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Blobel</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells</article-title><source>Science</source><volume>361</volume><fpage>285</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1126/science.aao0932</pub-id><pub-id pub-id-type="pmid">30026227</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishimura</surname> <given-names>R</given-names></name><name><surname>Nagy</surname> <given-names>G</given-names></name><name><surname>Dotu</surname> <given-names>I</given-names></name><name><surname>Chuang</surname> <given-names>JH</given-names></name><name><surname>Ackerman</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation</article-title><source>eLife</source><volume>5</volume><elocation-id>568</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.14295</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khajuria</surname> <given-names>RK</given-names></name><name><surname>Munschauer</surname> <given-names>M</given-names></name><name><surname>Ulirsch</surname> <given-names>JC</given-names></name><name><surname>Fiorini</surname> <given-names>C</given-names></name><name><surname>Ludwig</surname> <given-names>LS</given-names></name><name><surname>McFarland</surname> <given-names>SK</given-names></name><name><surname>Abdulhay</surname> <given-names>NJ</given-names></name><name><surname>Specht</surname> <given-names>H</given-names></name><name><surname>Keshishian</surname> <given-names>H</given-names></name><name><surname>Mani</surname> <given-names>DR</given-names></name><name><surname>Jovanovic</surname> <given-names>M</given-names></name><name><surname>Ellis</surname> <given-names>SR</given-names></name><name><surname>Fulco</surname> <given-names>CP</given-names></name><name><surname>Engreitz</surname> <given-names>JM</given-names></name><name><surname>Schütz</surname> <given-names>S</given-names></name><name><surname>Lian</surname> <given-names>J</given-names></name><name><surname>Gripp</surname> <given-names>KW</given-names></name><name><surname>Weinberg</surname> <given-names>OK</given-names></name><name><surname>Pinkus</surname> <given-names>GS</given-names></name><name><surname>Gehrke</surname> <given-names>L</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Gazda</surname> <given-names>HT</given-names></name><name><surname>Lee</surname> <given-names>WY</given-names></name><name><surname>Panse</surname> <given-names>VG</given-names></name><name><surname>Carr</surname> <given-names>SA</given-names></name><name><surname>Sankaran</surname> <given-names>VG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis</article-title><source>Cell</source><volume>173</volume><fpage>90</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.02.036</pub-id><pub-id pub-id-type="pmid">29551269</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimanius</surname> <given-names>D</given-names></name><name><surname>Forsberg</surname> <given-names>BO</given-names></name><name><surname>Scheres</surname> <given-names>SH</given-names></name><name><surname>Lindahl</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2</article-title><source>eLife</source><volume>5</volume><elocation-id>e18722</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.18722</pub-id><pub-id pub-id-type="pmid">27845625</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kressler</surname> <given-names>D</given-names></name><name><surname>Hurt</surname> <given-names>E</given-names></name><name><surname>Baβler</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Driving ribosome assembly</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1803</volume><fpage>673</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2009.10.009</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landry</surname> <given-names>DM</given-names></name><name><surname>Hertz</surname> <given-names>MI</given-names></name><name><surname>Thompson</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>RPS25 is essential for translation initiation by the Dicistroviridae and hepatitis C viral IRESs</article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>2753</fpage><lpage>2764</lpage><pub-id pub-id-type="doi">10.1101/gad.1832209</pub-id><pub-id pub-id-type="pmid">19952110</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Rijkers</surname> <given-names>DT</given-names></name><name><surname>Post</surname> <given-names>H</given-names></name><name><surname>Heck</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Proteome-wide profiling of protein assemblies by cross-linking mass spectrometry</article-title><source>Nature Methods</source><volume>12</volume><fpage>1179</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3603</pub-id><pub-id pub-id-type="pmid">26414014</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>B</given-names></name><name><surname>Qian</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Characterizing inactive ribosomes in translational profiling</article-title><source>Translation</source><volume>4</volume><elocation-id>e1138018</elocation-id><pub-id pub-id-type="doi">10.1080/21690731.2015.1138018</pub-id><pub-id pub-id-type="pmid">27335722</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ljungström</surname> <given-names>V</given-names></name><name><surname>Cortese</surname> <given-names>D</given-names></name><name><surname>Young</surname> <given-names>E</given-names></name><name><surname>Pandzic</surname> <given-names>T</given-names></name><name><surname>Mansouri</surname> <given-names>L</given-names></name><name><surname>Plevova</surname> <given-names>K</given-names></name><name><surname>Ntoufa</surname> <given-names>S</given-names></name><name><surname>Baliakas</surname> <given-names>P</given-names></name><name><surname>Clifford</surname> <given-names>R</given-names></name><name><surname>Sutton</surname> <given-names>LA</given-names></name><name><surname>Blakemore</surname> <given-names>SJ</given-names></name><name><surname>Stavroyianni</surname> <given-names>N</given-names></name><name><surname>Agathangelidis</surname> <given-names>A</given-names></name><name><surname>Rossi</surname> <given-names>D</given-names></name><name><surname>Höglund</surname> <given-names>M</given-names></name><name><surname>Kotaskova</surname> <given-names>J</given-names></name><name><surname>Juliusson</surname> <given-names>G</given-names></name><name><surname>Belessi</surname> <given-names>C</given-names></name><name><surname>Chiorazzi</surname> <given-names>N</given-names></name><name><surname>Panagiotidis</surname> <given-names>P</given-names></name><name><surname>Langerak</surname> <given-names>AW</given-names></name><name><surname>Smedby</surname> <given-names>KE</given-names></name><name><surname>Oscier</surname> <given-names>D</given-names></name><name><surname>Gaidano</surname> <given-names>G</given-names></name><name><surname>Schuh</surname> <given-names>A</given-names></name><name><surname>Davi</surname> <given-names>F</given-names></name><name><surname>Pott</surname> <given-names>C</given-names></name><name><surname>Strefford</surname> <given-names>JC</given-names></name><name><surname>Trentin</surname> <given-names>L</given-names></name><name><surname>Pospisilova</surname> <given-names>S</given-names></name><name><surname>Ghia</surname> <given-names>P</given-names></name><name><surname>Stamatopoulos</surname> <given-names>K</given-names></name><name><surname>Sjöblom</surname> <given-names>T</given-names></name><name><surname>Rosenquist</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations</article-title><source>Blood</source><volume>127</volume><fpage>1007</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1182/blood-2015-10-674572</pub-id><pub-id pub-id-type="pmid">26675346</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>EW</given-names></name><name><surname>Wangen</surname> <given-names>J</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name><name><surname>Ingolia</surname> <given-names>NT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dynamic regulation of a ribosome rescue pathway in erythroid cells and platelets</article-title><source>Cell Reports</source><volume>17</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.088</pub-id><pub-id pub-id-type="pmid">27681415</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname> <given-names>A</given-names></name><name><surname>Eisenbraun</surname> <given-names>B</given-names></name><name><surname>Key</surname> <given-names>J</given-names></name><name><surname>Sanschagrin</surname> <given-names>PC</given-names></name><name><surname>Timony</surname> <given-names>MA</given-names></name><name><surname>Ottaviano</surname> <given-names>M</given-names></name><name><surname>Sliz</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Collaboration gets the most out of software</article-title><source>eLife</source><volume>2</volume><elocation-id>e01456</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01456</pub-id><pub-id pub-id-type="pmid">24040512</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narla</surname> <given-names>A</given-names></name><name><surname>Ebert</surname> <given-names>BL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ribosomopathies: human disorders of ribosome dysfunction</article-title><source>Blood</source><volume>115</volume><fpage>3196</fpage><lpage>3205</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-10-178129</pub-id><pub-id pub-id-type="pmid">20194897</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natchiar</surname> <given-names>SK</given-names></name><name><surname>Myasnikov</surname> <given-names>AG</given-names></name><name><surname>Kratzat</surname> <given-names>H</given-names></name><name><surname>Hazemann</surname> <given-names>I</given-names></name><name><surname>Klaholz</surname> <given-names>BP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Visualization of chemical modifications in the human 80S ribosome structure</article-title><source>Nature</source><volume>372</volume><fpage>472</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1038/nature24482</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>AT</given-names></name><name><surname>Prado</surname> <given-names>MA</given-names></name><name><surname>Schmidt</surname> <given-names>PJ</given-names></name><name><surname>Sendamarai</surname> <given-names>AK</given-names></name><name><surname>Wilson-Grady</surname> <given-names>JT</given-names></name><name><surname>Min</surname> <given-names>M</given-names></name><name><surname>Campagna</surname> <given-names>DR</given-names></name><name><surname>Tian</surname> <given-names>G</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Dederer</surname> <given-names>V</given-names></name><name><surname>Kawan</surname> <given-names>M</given-names></name><name><surname>Kuehnle</surname> <given-names>N</given-names></name><name><surname>Paulo</surname> <given-names>JA</given-names></name><name><surname>Yao</surname> <given-names>Y</given-names></name><name><surname>Weiss</surname> <given-names>MJ</given-names></name><name><surname>Justice</surname> <given-names>MJ</given-names></name><name><surname>Gygi</surname> <given-names>SP</given-names></name><name><surname>Fleming</surname> <given-names>MD</given-names></name><name><surname>Finley</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>UBE2O remodels the proteome during terminal erythroid differentiation</article-title><source>Science</source><volume>357</volume><elocation-id>eaan0218</elocation-id><pub-id pub-id-type="doi">10.1126/science.aan0218</pub-id><pub-id pub-id-type="pmid">28774900</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrino</surname> <given-names>S</given-names></name><name><surname>Demeshkina</surname> <given-names>N</given-names></name><name><surname>Mancera-Martinez</surname> <given-names>E</given-names></name><name><surname>Melnikov</surname> <given-names>S</given-names></name><name><surname>Simonetti</surname> <given-names>A</given-names></name><name><surname>Myasnikov</surname> <given-names>A</given-names></name><name><surname>Yusupov</surname> <given-names>M</given-names></name><name><surname>Yusupova</surname> <given-names>G</given-names></name><name><surname>Hashem</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structural insights into the role of diphthamide on elongation factor 2 in mRNA Reading-Frame maintenance</article-title><source>Journal of Molecular Biology</source><volume>430</volume><fpage>2677</fpage><lpage>2687</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2018.06.006</pub-id><pub-id pub-id-type="pmid">29886014</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname> <given-names>EF</given-names></name><name><surname>Goddard</surname> <given-names>TD</given-names></name><name><surname>Huang</surname> <given-names>CC</given-names></name><name><surname>Couch</surname> <given-names>GS</given-names></name><name><surname>Greenblatt</surname> <given-names>DM</given-names></name><name><surname>Meng</surname> <given-names>EC</given-names></name><name><surname>Ferrin</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>UCSF chimera--a visualization system for exploratory research and analysis</article-title><source>Journal of Computational Chemistry</source><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id><pub-id pub-id-type="pmid">15264254</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quade</surname> <given-names>N</given-names></name><name><surname>Boehringer</surname> <given-names>D</given-names></name><name><surname>Leibundgut</surname> <given-names>M</given-names></name><name><surname>van den Heuvel</surname> <given-names>J</given-names></name><name><surname>Ban</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cryo-EM structure of hepatitis C virus IRES bound to the human ribosome at 3.9-Å resolution</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7646</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8646</pub-id><pub-id pub-id-type="pmid">26155016</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname> <given-names>M</given-names></name><name><surname>Wek</surname> <given-names>RC</given-names></name><name><surname>Hinnebusch</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Ribosome association of GCN2 protein kinase, a translational activator of the GCN4 gene of Saccharomyces cerevisiae</article-title><source>Molecular and Cellular Biology</source><volume>11</volume><fpage>3027</fpage><lpage>3036</lpage><pub-id pub-id-type="doi">10.1128/MCB.11.6.3027</pub-id><pub-id pub-id-type="pmid">2038314</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname> <given-names>PB</given-names></name><name><surname>Henderson</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy</article-title><source>Journal of Molecular Biology</source><volume>333</volume><fpage>721</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2003.07.013</pub-id><pub-id pub-id-type="pmid">14568533</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowley</surname> <given-names>PT</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>Protein synthesis in reticulocytes maturing in vivo</article-title><source>Nature</source><volume>208</volume><fpage>244</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1038/208244a0</pub-id><pub-id pub-id-type="pmid">5880622</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheres</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Semi-automated selection of cryo-EM particles in RELION-1.3</article-title><source>Journal of Structural Biology</source><volume>189</volume><fpage>114</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2014.11.010</pub-id><pub-id pub-id-type="pmid">25486611</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname> <given-names>S</given-names></name><name><surname>Murray</surname> <given-names>J</given-names></name><name><surname>Brown</surname> <given-names>A</given-names></name><name><surname>Taunton</surname> <given-names>J</given-names></name><name><surname>Ramakrishnan</surname> <given-names>V</given-names></name><name><surname>Hegde</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Decoding mammalian Ribosome-mRNA states by translational GTPase complexes</article-title><source>Cell</source><volume>167</volume><fpage>1229</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.046</pub-id><pub-id pub-id-type="pmid">27863242</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>Z</given-names></name><name><surname>Fujii</surname> <given-names>K</given-names></name><name><surname>Kovary</surname> <given-names>KM</given-names></name><name><surname>Genuth</surname> <given-names>NR</given-names></name><name><surname>Röst</surname> <given-names>HL</given-names></name><name><surname>Teruel</surname> <given-names>MN</given-names></name><name><surname>Barna</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Heterogeneous ribosomes preferentially translate distinct subpools of mRNAs Genome-wide</article-title><source>Molecular Cell</source><volume>67</volume><fpage>71</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.05.021</pub-id><pub-id pub-id-type="pmid">28625553</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simsek</surname> <given-names>D</given-names></name><name><surname>Tiu</surname> <given-names>GC</given-names></name><name><surname>Flynn</surname> <given-names>RA</given-names></name><name><surname>Byeon</surname> <given-names>GW</given-names></name><name><surname>Leppek</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>AF</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Barna</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The mammalian Ribo-interactome reveals ribosome functional diversity and heterogeneity</article-title><source>Cell</source><volume>169</volume><fpage>1051</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.022</pub-id><pub-id pub-id-type="pmid">28575669</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>DW</given-names></name><name><surname>McNamara</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Specialization of rabbit reticulocyte transfer RNA content for hemoglobin synthesis</article-title><source>Science</source><volume>171</volume><fpage>577</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1126/science.171.3971.577</pub-id><pub-id pub-id-type="pmid">5539722</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tirone</surname> <given-names>F</given-names></name><name><surname>Shooter</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Early gene regulation by nerve growth factor in PC12 cells: <italic>induction of an interferon-related gene</italic></article-title><source>PNAS</source><volume>86</volume><fpage>2088</fpage><lpage>2092</lpage><pub-id pub-id-type="doi">10.1073/pnas.86.6.2088</pub-id><pub-id pub-id-type="pmid">2467301</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Elzen</surname> <given-names>AM</given-names></name><name><surname>Schuller</surname> <given-names>A</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name><name><surname>Séraphin</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dom34-Hbs1 mediated dissociation of inactive 80S ribosomes promotes restart of translation after stress</article-title><source>The EMBO Journal</source><volume>33</volume><fpage>265</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1002/embj.201386123</pub-id><pub-id pub-id-type="pmid">24424461</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dyke</surname> <given-names>N</given-names></name><name><surname>Baby</surname> <given-names>J</given-names></name><name><surname>Van Dyke</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Stm1p, a ribosome-associated protein, is important for protein synthesis in Saccharomyces cerevisiae under nutritional stress conditions</article-title><source>Journal of Molecular Biology</source><volume>358</volume><fpage>1023</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2006.03.018</pub-id><pub-id pub-id-type="pmid">16580682</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dyke</surname> <given-names>N</given-names></name><name><surname>Chanchorn</surname> <given-names>E</given-names></name><name><surname>Van Dyke</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The Saccharomyces cerevisiae protein Stm1p facilitates ribosome preservation during quiescence</article-title><source>Biochemical and Biophysical Research Communications</source><volume>430</volume><fpage>745</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2012.11.078</pub-id><pub-id pub-id-type="pmid">23206692</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varnum</surname> <given-names>BC</given-names></name><name><surname>Lim</surname> <given-names>RW</given-names></name><name><surname>Herschman</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Characterization of TIS7, a gene induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate</article-title><source>Oncogene</source><volume>4</volume><fpage>1263</fpage><lpage>1265</lpage><pub-id pub-id-type="pmid">2797820</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vietor</surname> <given-names>I</given-names></name><name><surname>Vadivelu</surname> <given-names>SK</given-names></name><name><surname>Wick</surname> <given-names>N</given-names></name><name><surname>Hoffman</surname> <given-names>R</given-names></name><name><surname>Cotten</surname> <given-names>M</given-names></name><name><surname>Seiser</surname> <given-names>C</given-names></name><name><surname>Fialka</surname> <given-names>I</given-names></name><name><surname>Wunderlich</surname> <given-names>W</given-names></name><name><surname>Haase</surname> <given-names>A</given-names></name><name><surname>Korinkova</surname> <given-names>G</given-names></name><name><surname>Brosch</surname> <given-names>G</given-names></name><name><surname>Huber</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>TIS7 interacts with the mammalian SIN3 histone deacetylase complex in epithelial cells</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>4621</fpage><lpage>4631</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdf461</pub-id><pub-id pub-id-type="pmid">12198164</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilas</surname> <given-names>JL</given-names></name><name><surname>Gómez-Blanco</surname> <given-names>J</given-names></name><name><surname>Conesa</surname> <given-names>P</given-names></name><name><surname>Melero</surname> <given-names>R</given-names></name><name><surname>Miguel de la Rosa-Trevín</surname> <given-names>J</given-names></name><name><surname>Otón</surname> <given-names>J</given-names></name><name><surname>Cuenca</surname> <given-names>J</given-names></name><name><surname>Marabini</surname> <given-names>R</given-names></name><name><surname>Carazo</surname> <given-names>JM</given-names></name><name><surname>Vargas</surname> <given-names>J</given-names></name><name><surname>Sorzano</surname> <given-names>COS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MonoRes: automatic and accurate estimation of local resolution for electron microscopy maps</article-title><source>Structure</source><volume>26</volume><fpage>337</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/j.str.2017.12.018</pub-id><pub-id pub-id-type="pmid">29395788</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visweswaraiah</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>SJ</given-names></name><name><surname>Hinnebusch</surname> <given-names>AG</given-names></name><name><surname>Sattlegger</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Overexpression of eukaryotic translation elongation factor 3 impairs Gcn2 protein activation</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>37757</fpage><lpage>37768</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.368266</pub-id><pub-id pub-id-type="pmid">22888004</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voorhees</surname> <given-names>RM</given-names></name><name><surname>Fernández</surname> <given-names>IS</given-names></name><name><surname>Scheres</surname> <given-names>SH</given-names></name><name><surname>Hegde</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Structure of the mammalian ribosome-Sec61 complex to 3.4 Å resolution</article-title><source>Cell</source><volume>157</volume><fpage>1632</fpage><lpage>1643</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.05.024</pub-id><pub-id pub-id-type="pmid">24930395</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The economics of ribosome biosynthesis in yeast</article-title><source>Trends in Biochemical Sciences</source><volume>24</volume><fpage>437</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/S0968-0004(99)01460-7</pub-id><pub-id pub-id-type="pmid">10542411</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wek</surname> <given-names>RC</given-names></name><name><surname>Jiang</surname> <given-names>HY</given-names></name><name><surname>Anthony</surname> <given-names>TG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Coping with stress: eIF2 kinases and translational control</article-title><source>Biochemical Society Transactions</source><volume>34</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1042/BST0340007</pub-id><pub-id pub-id-type="pmid">16246168</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>H</given-names></name><name><surname>Collier</surname> <given-names>M</given-names></name><name><surname>Loerke</surname> <given-names>J</given-names></name><name><surname>Ismer</surname> <given-names>J</given-names></name><name><surname>Schmidt</surname> <given-names>A</given-names></name><name><surname>Hilal</surname> <given-names>T</given-names></name><name><surname>Sprink</surname> <given-names>T</given-names></name><name><surname>Yamamoto</surname> <given-names>K</given-names></name><name><surname>Mielke</surname> <given-names>T</given-names></name><name><surname>Bürger</surname> <given-names>J</given-names></name><name><surname>Shaikh</surname> <given-names>TR</given-names></name><name><surname>Dabrowski</surname> <given-names>M</given-names></name><name><surname>Hildebrand</surname> <given-names>PW</given-names></name><name><surname>Scheerer</surname> <given-names>P</given-names></name><name><surname>Spahn</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Molecular architecture of the ribosome-bound hepatitis C virus internal ribosomal entry site RNA</article-title><source>The EMBO Journal</source><volume>34</volume><fpage>3042</fpage><lpage>3058</lpage><pub-id pub-id-type="doi">10.15252/embj.201592469</pub-id><pub-id pub-id-type="pmid">26604301</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>I-TASSER server for protein 3D structure prediction</article-title><source>BMC Bioinformatics</source><volume>9</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-9-40</pub-id><pub-id pub-id-type="pmid">18215316</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gctf: real-time CTF determination and correction</article-title><source>Journal of Structural Biology</source><volume>193</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2015.11.003</pub-id><pub-id pub-id-type="pmid">26592709</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Hong</surname> <given-names>S</given-names></name><name><surname>Ruangprasert</surname> <given-names>A</given-names></name><name><surname>Skiniotis</surname> <given-names>G</given-names></name><name><surname>Dunham</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Alternative mode of E-Site tRNA binding in the presence of a downstream mRNA stem loop at the entrance channel</article-title><source>Structure</source><volume>26</volume><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.str.2018.01.013</pub-id><pub-id pub-id-type="pmid">29456023</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>C</given-names></name><name><surname>Datta</surname> <given-names>S</given-names></name><name><surname>Mandal</surname> <given-names>P</given-names></name><name><surname>Xu</surname> <given-names>S</given-names></name><name><surname>Hamilton</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Stress-sensitive regulation of IFRD1 mRNA decay is mediated by an upstream open reading frame</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>8552</fpage><lpage>8562</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.070920</pub-id><pub-id pub-id-type="pmid">20080976</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>SQ</given-names></name><name><surname>Palovcak</surname> <given-names>E</given-names></name><name><surname>Armache</surname> <given-names>JP</given-names></name><name><surname>Verba</surname> <given-names>KA</given-names></name><name><surname>Cheng</surname> <given-names>Y</given-names></name><name><surname>Agard</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</article-title><source>Nature Methods</source><volume>14</volume><fpage>331</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4193</pub-id><pub-id pub-id-type="pmid">28250466</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.40486.042</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Sonenberg</surname><given-names>Nahum</given-names></name><role>Reviewing Editor</role><aff><institution>McGill University</institution><country>Canada</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Structures of translationally inactivated mammalian ribosomes&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by James Manley as the Senior Editor, a Reviewing Editor and three peer reviewers. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The authors report cryo-EM structures of mammalian 80S ribosomes bound with SERBP1•eEF2 or with IFRD2. Importantly, they document a tRNA-binding, which differs from the canonical A, P and E sites. The structures allow near-atomic interpretation of interactions between the ribosomes, SERBP1 and eEF2, shedding new light on the mechanism of SERBP1. The work describes several new findings that will be of interest to researchers in and beyond the ribosome field.</p><p>Essential revisions:</p><p>The reviewers believe that your paper contains novel and interesting data, but that the paper needs revisions to (1) include reference to biochemical/biophysical work in the field (please see in the reviews below) and (2) provide a clearer explanation/review of the biological relevance of these structures as &quot;inactivated&quot; complexes. As you can see reviewer #1, in particular, is concerned whether the &quot;inactive&quot; states are just an artifact of isolation and treatment or whether they represent true inactive states that might reflect different physiological conditions. Also, there is the possibility that they represent intermediates (i.e. perhaps during recycling)?</p><p><italic>Reviewer #1:</italic> </p><p>This is an interesting manuscript that reports on the structure of complexes of &quot;inactivated&quot; ribosomes. As such, these may offer little new insight into the process of translation but may be very important in elements relating to the regulation of translation and availability of ribosomal subunits. A major concern for this paper is whether the structures determined are biologically relevant as these inactive complexes have not been shown to directly be related to any process within the cell that might have generated such inactive particles (i.e. either as soluble complexes or as stress granules). Secondly, in the partial purification of ribosomal complexes, the authors use high speed centrifugation which is known to cause inactivation of ribosomes (Lu et al., 1997 or Scheck and Landau, 1982). Thus, there is the concern as to whether the complexes observed represent native structures or ones altered by hydrostatic pressure. However, that said, it is impressive that the authors can resolve so many structures from a large dataset and offers promise for the ability to readily obtain almost any ribosomal structure.</p><p>1) Title – it is not clear that these ribosomes have been inactivated, but rather that they are in an inactive state as the A, P and E sites or mRNA channel are blocked. There is the possibility that some of these complexes (i.e. 80S•P•E•eRF1•ABCE1) may represent intermediates in the translation cycle (and therefore, should not be considered inactive).</p><p>2) The authors use affinity tags for purification, but it is not clear that this process has actually worked. How is this population different from one where no affinity purification is used?</p><p>3) It is anticipated that a comparison of the yield of different proteins as determined by mass spectrometry should be reflected in the types of particles that are examined. Is there any data that would allow one to relate the amount of protein (as reflected in Supplementary file 1 to the different ribosomal classes as identified in Table 1)?</p><p>4) Supplementary file 1 – Initiation factors: the authors should identify the subunits of eIF2 as α, β and γ so as to not confuse the reader with eIF2A, a separate initiation factor (MW 65,000). Secondly, is there any explanation as to why eIF1, 1A, 5 or 5B were not found?</p><p>5) IFRD2 – The authors have failed to indicate that rabbit reticulocytes are essentially &quot;interferon treated cells&quot; in that they have elevated levels of several normally interferon induced proteins (PKR, oligo(A) synthase and RNAse L). Thus, this complex is likely to not normally be present in most tissues in the absence of exposure to interferon.</p><p>6) For the Z site tRNA, is it possible that this unique conformation is influenced by eIF5A which binds in this vicinity (i.e. would this small protein have been seen?)?</p><p>7) Discussion section – &quot;tRNA binding to the Z site is more likely during periods of elevated deacylated tRNA levels.&quot;. This is not likely to occur as a slight increase in deacylated tRNA leads to the phosphorylation of eIF2 and the shutoff of protein synthesis (thus sparing the use of aminoacyl-tRNAs).</p><p><italic>Reviewer #2:</italic> </p><p>Brown and co-authors describe cryo-EM structures of mammalian 80S ribosomes bound with SERBP1•eEF2 (at a higher resolution than the previously published 80S•SERBP1•eEF2 structural work) or with IFRD2. In addition, a tRNA-binding site is described, which differs from the canonical A, P and E sites. These results were obtained by re-evaluation of a previously published cryo-EM data set. The structures allow near-atomic interpretation of interactions between the ribosomes, SERBP1 and eEF2, bringing insights into the mechanism of SERBP1, however the authors' description of the mechanism is not clear (see below). The 80S•IFRD2 structure is an exciting finding, which identifies a new protein's role in translation regulation. The new tRNA position near the E site echoes a recent work on the bacterial ribosome. The authors propose that this position is on the pathway of deacyl-tRNA dissociation from the E site. Overall this work describes several new findings that will be of interest to researchers in and beyond the ribosome field.</p><p>The following changes/clarifications are suggested:</p><p>1) The mechanistic implications of SERBP1•eEF2 complex remain unclear. Based on the finding of SERBP1 bound together with eEF2, the authors propose that SERBP1 depletes cellular eEF2. First, it would be helpful to expand the discussion and mention that yeast homologue Stm1 binds yeast ribosomes without eEF2. Do the mechanisms of translation regulation by Stm1 and SERBP1 differ in that the latter depletes not only the 80S but also eEF2? Alternatively, the authors may have missed 80S•SERBP1 particles in their data set. Such particles may even be more abundant than 80S•SERBP1•eEF2 but also more dynamic, thus difficult to average and classify. Second, the mechanistic description of how SERBP1 prevents eEF2 dissociation remains vague. Comparison with other available eEF2 structures (with sordarin or other drugs and/or GDPNP/GDP nucleotides) might bring insights into how the conformational dynamics of eEF2 and/or the ribosome are affected by SERBP1.</p><p>2) IFRD2 is proposed to regulate translation by binding to non-translating 80S. But could IFRD2 also bind vacant 40S and prevent translation initiation?</p><p>3) Describe the rotational state of the 80S bound with P-tRNA and Z-tRNA (likely non-rotated, but it would help to state this in the paper). Does IFRD2 induce a different 80S conformation?</p><p><italic>Reviewer #3:</italic> </p><p>This manuscript describes the results of a refined analysis of a data set of nearly 1 million ribosome particles obtained from an in vitro rabbit reticulocyte translation reaction in which a dominant negative release factor had been added to enrich for translation termination complexes (Brown et al., 2015b). Evidently, individual complexes only represent a small portion (5-25%) of the ribosomes isolated by the procedures used and the authors have mined this reaction for complexes other than those that have already been published to define 9 new structures (described in summary in Figure 1). There is little information in the present manuscript that describes how the complexes examined here were specifically obtained from the reticulocyte lysate, but it would appear that they work under conditions in which only 80S particles form and that the isolated 80S peak is filled with a diverse array of distinct ribosome complexes. In the Brown et al., 2015 paper it appears to describe a FLAG-tag pull down of the nascent peptide, where focus was given to the eRF1-trapped sub-population of complexes. One of the 9 complexes defined here appears to be the same structure as that which was published in Brown et al., 2015b (the eRF1-ABCE1 POST complex), indicating a duplication or positive control of sorts. While I might be able to understand how the other P-site tRNA-containing complexes were isolated by a nascent polypeptide-directed pull-down approach, it is unclear how the complexes lacking P-site tRNA were obtained (i.e. the focus of the present investigations). I would strongly suggest further clarification on these points for the sake of reproducibility.</p><p>The two translationally inactive complexes discussed in detail in Figure 2, Figure 3 and Figure 4 are certainly interesting in regards to the mechanisms by which cells may &quot;store&quot; excess ribosomes and the quality of the data appear sufficient enough to support the claims that the authors make, which are largely qualitative descriptions of the SERBP1 and IFRD2 binding sites and the global positioning of the deacylated tRNA within the E site. In this regard, I think the paper is perfectly suitable for publication.</p><p>What appears to need further clarification and elaboration is the discussion surrounding the &quot;Z&quot; site for tRNA binding. Alternative positions for E-site tRNA have been described since the early 80s in the early fluorescence studies of eukaryotic ribosomes (Robertson and Wintermeyer, 1987; Rodnina and Wintermeyer, 1992). Movements of deacylated tRNA within the E site have also been specifically described in recent single-molecule fluorescence studies (Ferguson et al., 2015 and references therein). Although the authors state that their &quot;Z&quot; site position may be similar or related to the position (E<sub>out</sub>) described by (Zhang et al., 2017), I don't see how they make this connection. I also don't understand the authors reference to the &quot;known role [of the L1 stalk] in escorting deacylated tRNA from the ribosome&quot;, citing two bodies of work in bacteria that make no such claim or data to support such a claim. In this regard, is it really wise to give it a name other than E' or something of the sort? I fear that re-naming it the &quot;Z&quot; site will significantly complicate its description in future publications. The new position the authors see is clearly an &quot;E site&quot; position, yes?</p><p>Aside from these major points, the paper certainly seems publishable in its present format from my perspective.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.40486.043</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>This is an interesting manuscript that reports on the structure of complexes of &quot;inactivated&quot; ribosomes. As such, these may offer little new insight into the process of translation but may be very important in elements relating to the regulation of translation and availability of ribosomal subunits. A major concern for this paper is whether the structures determined are biologically relevant as these inactive complexes have not been shown to directly be related to any process within the cell that might have generated such inactive particles (i.e. either as soluble complexes or as stress granules).</p></disp-quote><p>Although SERBP1/Stm1 has been implicated in stress responses (Van Dyke et al., 2006)(Lee et al., 2014), inactive ribosomes may also occur outside periods of stress. Both SERBP1 and IFRD2 are expressed in most tissues at moderate levels (https://www.proteinatlas.org/ENSG00000214706-IFRD2/tissue and https://www.proteinatlas.org/ENSG00000142864-SERBP1/tissue) and are detected to be associated with ribosomes in unstressed cells (Simsek et al., 2017). This suggests that a percentage of ribosomes exist in inactivate states even in cells not undergoing stress. As we mention in the paper, one possibility is that ribosomes are inactivated as part of translational reprogramming that occurs during differentiation. As our ribosomes were purified from reticulocytes, the penultimate stage of erythrocyte differentiation, this may explain the presence of inactive ribosomes in our sample. Consistent with this, we observe higher IFRD2 levels in reticulocytes than in HEK293T cells (Figure 3—figure supplement 3B).</p><disp-quote content-type="editor-comment"><p>Secondly, in the partial purification of ribosomal complexes, the authors use high speed centrifugation which is known to cause inactivation of ribosomes (Lu et al., 1997 or Scheck and Landau, 1982). Thus, there is the concern as to whether the complexes observed represent native structures or ones altered by hydrostatic pressure. However, that said, it is impressive that the authors can resolve so many structures from a large dataset and offers promise for the ability to readily obtain almost any ribosomal structure.</p></disp-quote><p>Though we cannot completely rule out the possibility that high-speed centrifugation may inactivate some reticulocyte ribosomes, we believe there is strong evidence that the structures of inactive ribosomes we analyze represent physiological complexes and are not the result of technical artifacts:</p><p>First, the ability to detect known intermediates of translation (Figure 1) demonstrates that our purification scheme is capable to retaining ribosomes in near-native states. In addition, using the same centrifugation conditions as in this manuscript, we can isolate ribosomal pellets that translate just as efficiently in fractionated cell-free translation systems as complete reticulocyte lysate (Shao and Hegde, 2011), suggesting that these centrifugation conditions do not significantly inactivate ribosomes. Similar centrifugation conditions are used to isolate ribosomes to generate other prokaryotic and eukaryotic cell-free translation systems (Spedding, 1990; Shimizu et al., 2001), including the translation system used in Lu et al., 1997. We think this is consistent with the studies by Lu et al., 1997 and Scheck and Landau, 1982, which primarily analyze ribosome activity after applying high-pressure treatments in closed pressure vessels, rather than by centrifugation.</p><p>Second, the interaction between IFRD2 and ribosomes is also detected in a mass spectrometry study that did not use high-speed centrifugation (Simsek et al., 2017), as well as in immunoprecipitations of Flag-tagged IFRD2 from 293T cell lysate that was not subject to centrifugation (Figure 3—figure supplement 3D). We also detect endogenous IFRD2 quantitatively associated with ribosomes in reticulocyte lysate before (Figure 3—figure supplement 3A) and after (Figure 3E) highspeed centrifugation. Finally, recombinant IFRD2 only weakly associates with ribosomes after centrifugation when incubated with lysate (<xref ref-type="fig" rid="respfig1">Author response image 1</xref>), unlike IFRD2 expressed in cells, which clearly interacts with ribosomes (<xref ref-type="fig" rid="respfig1">Author response image 1</xref>, Figure 3—figure supplement 3B-E). Similarly, the association of SERBP1/Stm1 with ribosomes has also been observed by different methods in the literature (Zinoviev et al., 2015). These observations all suggest that these complexes assemble in physiological conditions and are not induced by centrifugation.</p><fig id="respfig1"><object-id pub-id-type="doi">10.7554/eLife.40486.017</object-id><label>Author response image 1.</label><caption><title>Assembly of IFRD2 onto ribosomes.</title><p>Recombinant IFRD2 purified from <italic>E. coli</italic> was incubated with cytosol isolated from HEK293T cells for 30 minutes at 32°C and subject to native size fractionation by centrifugation on a 10-50% sucrose gradient. Eleven fractions were collected from the top of the gradient and analyzed by SDS-PAGE and immunoblotting for the recombinant IFRD2 (top blot; quantified by blue curve). This revealed that only minor co-association of IFRD2 in ribosomal (80S) fractions. In contrast, transiently transfecting IFRD2 into HEK293T cells, followed by cytosol isolation and size fractionation (bottom plot; quantified by orange curve) reveals a distinct peak of IFRD2 co-association in ribosomal fractions (red arrow).</p></caption><graphic mime-subtype="png" mimetype="image" xlink:href="elife-40486-resp-fig1-v2"/></fig><disp-quote content-type="editor-comment"><p>1) Title – it is not clear that these ribosomes have been inactivated, but rather that they are in an inactive state as the A, P and E sites or mRNA channel are blocked. There is the possibility that some of these complexes (i.e. 80S•P•E•eRF1•ABCE1) may represent intermediates in the translation cycle (and therefore, should not be considered inactive).</p></disp-quote><p>As shown in Figure 1 we only consider ribosomal complexes containing SERBP1 and IFRD2 to be inactive. To more accurately describe these complexes, we have changed the title to “Structures of translationally inactive mammalian ribosomes”.</p><disp-quote content-type="editor-comment"><p>2) The authors use affinity tags for purification, but it is not clear that this process has actually worked. How is this population different from one where no affinity purification is used?</p></disp-quote><p>We address this comment in detail in response to reviewer #3.</p><disp-quote content-type="editor-comment"><p>3) It is anticipated that a comparison of the yield of different proteins as determined by mass spectrometry should be reflected in the types of particles that are examined. Is there any data that would allow one to relate the amount of protein (as reflected in Supplementary file 1 to the different ribosomal classes as identified in Table 1)?</p></disp-quote><p>Our mass spectrometry analysis was run for protein detection of SDS-PAGE gel lanes and not quantification (e.g. via multiplexing of different samples for comparison). As proteins respond differently to trypsin digestion, some peptides ionize better than others, and detection efficiencies for ions with different <italic>m/z</italic> values are unequal, the peptides detected may not fully correlate with the protein composition of the sample. We do detect many more proteins by mass spectrometry (Supplementary file 1) than we identified by cryo-EM analysis (Table 1). This may be due to numerous factors, including relative protein abundance, mRNA-binding proteins that do not directly contact the ribosome, or the inability to visualize flexible ribosome-binding proteins.</p><disp-quote content-type="editor-comment"><p>4) Supplementary file 1 – Initiation factors: the authors should identify the subunits of eIF2 as α, β and γ so as to not confuse the reader with eIF2A, a separate initiation factor (MW 65,000). Secondly, is there any explanation as to why eIF1, 1A, 5 or 5B were not found?</p></disp-quote><p>We have edited Supplementary file 1 to include the names of the eIF2 subunits alongside their Uniprot IDs. We note that eIF5B did appear in our mass spectrometry analysis (G1TRL5_RABIT, IF2P_HUMAN). The absence of other initiation factors may be due to their absence from the sample, presence at concentrations below the detection limit, or technical limitations of the mass spectrometry experiment, particularly given the small sizes of eIF1 and 1A.</p><disp-quote content-type="editor-comment"><p>5) IFRD2 – The authors have failed to indicate that rabbit reticulocytes are essentially &quot;interferon treated cells&quot; in that they have elevated levels of several normally interferon induced proteins (PKR, oligo(A) synthase and RNAse L). Thus, this complex is likely to not normally be present in most tissues in the absence of exposure to interferon.</p></disp-quote><p>As we mention in the manuscript, the name “interferon-related developmental regulator” appears to be a misnomer that originated from a mistaken sequence alignment with mouse interferon-b (Tirone et al., 1989). We do not know of a direct connection between IFRD2 expression or function and interferon signaling, though we cannot exclude the possibility that IFRD2, like established interferon-induced proteins, may be upregulated in certain situations to inhibit translation. In addition, IFRD2 is expressed in many tissues (https://www.proteinatlas.org/ENSG00000214706-IFRD2/tissue), and we can also detect low levels of endogenous IFRD2 in HEK293T cells (Figure 3—figure supplement 3B). We therefore think that IFRD2 is a general mechanism of translationally repressing ribosomes.</p><disp-quote content-type="editor-comment"><p>6) For the Z site tRNA, is it possible that this unique conformation is influenced by eIF5A which binds in this vicinity (i.e. would this small protein have been seen?)?</p></disp-quote><p>eIF5A was our first thought when we saw density in this area prior to classification. However, following extensive classification, we see no evidence of eIF5A bound to any ribosomes. eIF5A has been observed in another cryo-EM study (Schmidt et al., 2016)</p><disp-quote content-type="editor-comment"><p>7) Discussion section – &quot;tRNA binding to the Z site is more likely during periods of elevated deacylated tRNA levels.&quot;. This is not likely to occur as a slight increase in deacylated tRNA leads to the phosphorylation of eIF2 and the shutoff of protein synthesis (thus sparing the use of aminoacyl-tRNAs).</p></disp-quote><p>Work in yeast has shown that phosphorylation of eIF2α is induced within 15 min of amino acid starvation (Zaborske et al., 2009). This means elevated concentrations of deacylated tRNA can occur even if only transiently before eIF2 phosphorylation dampens translation. We have rephrased the text to make this clearer.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>1) The mechanistic implications of SERBP1•eEF2 complex remain unclear. Based on the finding of SERBP1 bound together with eEF2, the authors propose that SERBP1 depletes cellular eEF2. First, it would be helpful to expand the discussion and mention that yeast homologue Stm1 binds yeast ribosomes without eEF2. Do the mechanisms of translation regulation by Stm1 and SERBP1 differ in that the latter depletes not only the 80S but also eEF2?</p></disp-quote><p>The thinking that Stm1 binds the yeast ribosome in the absence of eEF2 is influenced by the absence of eEF2 in structures of the yeast 80S in complex with Stm1 (Ben-Shem et al., 2011). However, work from Nono Takeuchi-Tomita’s lab provides evidence that Stm1 stabilizes eEF2 on the yeast ribosome (Hayashi et al., 2017). It is therefore possible that Stm1 and SERBP1 function similarly within cells to deplete eEF2, but yeast eEF2 was lost during purification or did not crystallize.</p><disp-quote content-type="editor-comment"><p>Alternatively, the authors may have missed 80S•SERBP1 particles in their data set. Such particles may even be more abundant than 80S•SERBP1•eEF2 but also more dynamic, thus difficult to average and classify. Second, the mechanistic description of how SERBP1 prevents eEF2 dissociation remains vague. Comparison with other available eEF2 structures (with sordarin or other drugs and/or GDPNP/GDP nucleotides) might bring insights into how the conformational dynamics of eEF2 and/or the ribosome are affected by SERBP1.</p></disp-quote><p>We agree with the reviewer that SERBP1 probably binds ribosomes in the absence of eEF2 and cannot discount the presence of 80S•SERBP1 in our dataset. However, as eEF2 is one of the most highly expressed proteins in cells, ribosome•SERBP1 complexes may quickly recruit eEF2.</p><p>The exact mechanism for how SERBP1 prevents eEF2 from dissociating from the ribosome is difficult to infer from our two structural snapshots. However, it is clear that SERBP1 does not prevent GTP hydrolysis or induce large displacements in orientations of the domains of eEF2. Rather, its mechanism of action may be similar to sordarin, an antibiotic that also does not prevent GTP hydrolysis or induce large structural changes yet still traps eEF2 on the ribosome. Sordarin binds in a pocket between domains III, IV and V and in doing so increases interdomain contacts and subtly constrain the domains in conformations that prevent release (Pellegrino et al., 2018). As SERBP1 interacts only with domain IV of eEF2, it is likely that SERBP1 constrains the interdomain movements necessary for release by locking domain IV in a fixed position in the A site. We have altered the text to include a more detailed proposal for how we expect SERBP1 to prevent eEF2 dissociation.</p><disp-quote content-type="editor-comment"><p>2) IFRD2 is proposed to regulate translation by binding to non-translating 80S. But could IFRD2 also bind vacant 40S and prevent translation initiation?</p></disp-quote><p>IFRD2 interacts with both the small and large subunits, suggesting that the interaction is most stable with 80S ribosomes. Additionally, our immunoprecipitation experiments with FLAG-tagged IFRD2 did not isolate any 40S•IFRD2 complexes (as judged from analysis of our micrographs). Despite these observations, we cannot preclude the possibility that IFRD2 binds vacant 40S subunits before recruiting 60S subunits and in some cases a tRNA bound at the Z site. Regardless of the assembly pathway, IFRD2 would function to repress translation.</p><disp-quote content-type="editor-comment"><p>3) Describe the rotational state of the 80S bound with P-tRNA and Z-tRNA (likely non-rotated, but it would help to state this in the paper). Does IFRD2 induce a different 80S conformation?</p></disp-quote><p>The ribosome is in a non-rotated state in the presence of IFRD2 and/or Z-site tRNA. We have added this information to the manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>[…] There is little information in the present manuscript that describes how the complexes examined here were specifically obtained from the reticulocyte lysate, but it would appear that they work under conditions in which only 80S particles form and that the isolated 80S peak is filled with a diverse array of distinct ribosome complexes. In the Brown et al., 2015 paper it appears to describe a FLAG-tag pull down of the nascent peptide, where focus was given to the eRF1-trapped sub-population of complexes. One of the 9 complexes defined here appears to be the same structure as that which was published in Brown et al., 2015b (the eRF1-ABCE1 POST complex), indicating a duplication or positive control of sorts. While I might be able to understand how the other P-site tRNA-containing complexes were isolated by a nascent polypeptide-directed pull-down approach, it is unclear how the complexes lacking P-site tRNA were obtained (i.e. the focus of the present investigations). I would strongly suggest further clarification on these points for the sake of reproducibility.</p></disp-quote><p>The original aim of the purification strategy was to isolate 80S•P•E•eRF1•ABCE1 complexes using a FLAG-tagged nascent chain and a catalytically inactive mutant of eRF1 in cell-free translational reactions. The complexes lacking peptidyl-tRNA are likely ribosomes that either co-associate with the target ribosome-nascent-chain complexes or bind non-specifically to the anti-FLAG beads during purification. This apparent co-association and/or non-specific binding also occurs in our experiments with FLAG-tagged IFRD2, where 75% of immunoprecipitated ribosomes observed by cryo-EM lack IFRD2. The phenomenon of achieving enrichment rather than homogeneity is widely reported with many target cryo-EM structures coming from about 10% of the total data, for example the ribosomal complexes described in Voorhees and Hegde, 2015; Shen et al., 2015; Braunger et al., 2018.</p><disp-quote content-type="editor-comment"><p>The two translationally inactive complexes discussed in detail in Figure 2, Figure 3 and Figure 4 are certainly interesting in regards to the mechanisms by which cells may &quot;store&quot; excess ribosomes and the quality of the data appear sufficient enough to support the claims that the authors make, which are largely qualitative descriptions of the SERBP1 and IFRD2 binding sites and the global positioning of the deacylated tRNA within the E site. In this regard, I think the paper is perfectly suitable for publication.</p><p>What appears to need further clarification and elaboration is the discussion surrounding the &quot;Z&quot; site for tRNA binding. Alternative positions for E-site tRNA have been described since the early 80s in the early fluorescence studies of eukaryotic ribosomes (Robertson and Wintermeyer, 1987; Rodnina and Wintermeyer, 1992). Movements of deacylated tRNA within the E site have also been specifically described in recent single-molecule fluorescence studies (Ferguson et al., 2015 and references therein). Although the authors state that their &quot;Z&quot; site position may be similar or related to the position (Eout) described (Zhang et al., 2017), I don't see how they make this connection. I also don't understand the authors reference to the &quot;known role [of the L1 stalk] in escorting deacylated tRNA from the ribosome&quot;, citing two bodies of work in bacteria that make no such claim or data to support such a claim. In this regard, is it really wise to give it a name other than E' or something of the sort? I fear that re-naming it the &quot;Z&quot; site will significantly complicate its description in future publications. The new position the authors see is clearly an &quot;E site&quot; position, yes?</p><p>Aside from these major points, the paper certainly seems publishable in its present format from my perspective.</p></disp-quote><p>We decided to call the site as the “Z site” for a number of reasons. Firstly, the naming of E-site intermediates in bacteria is confusing and we did not want to add to this confusion. Published terms include Eout (Zhang et al., 2017), E2 (Agrawal et al., 2000), E´ (Robertson et al., 1986), and F site (Wower et al., 2000). We felt a different letter would help distinguish the site from reported intermediates in bacterial ribosomes. Secondly, using E´ (or similar) may give the impression that this tRNA position is definitely an intermediate of ejection from the E site. Although this is a plausible explanation, we cannot ignore the possibility that a tRNA can only bind to the Z site when the normal passage of tRNAs through the ribosome is stopped. Thirdly, “Z” as the last letter of the alphabet evokes the extreme position on the ribosome adopted by the tRNA.</p><p>The comparison with Eout (Zhang et al., 2017) was based on the way in which the anti-codon stem-loop of the tRNAs in both complexes interact with the extremity of the small subunit. However, given that the Z-site is specific to eukaryotes, we have removed this comparison. We have also removed the references to the role of the L1 in escorting deacylated tRNAs, except to say that the L1 stalk interacts with all known tRNA ejection intermediates.</p></body></sub-article></article>